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Abstract 
There are different studies on the impact of tribbles (TRIBs) on immunity, metabolic, and 
cardiovascular diseases. Interestingly, the current study identified TRIB3 as a gene that may be 
involved in the development of hyperlipidemia, inflammatory diseases and insulin sensitivity. 
Hence our interest in the mechanisms by which TRIB3 may regulate specific aspects of lipid 
homeostasis, blood glucose level and neutrophil function. It was found that neutrophil 
chemotaxis towards KC and fMLP, was dependent upon on p38 MAPK and PI3K, which could 
be controlled by TRIB3. TRIB3 regulates cytokine production, as absence of TRIB3 increased 
murine interleukin-13 (IL-13) level in thioglycollate-induced peritonitis significantly. Genetic 
deletion of TRIB3 prevented the increase in circulating leukocyte levels considerably, 
increased neutrophil migration towards the peritoneum; elevated neutrophil levels persisted in 
thioglycollate-induced peritonitis. These data supported the theory that TRIB3 deficiency and 
high fat diet (HFD) have an effect on leukocyte count in peritoneum and blood. However, their 
effect is varied and appeared to depend on a range of factors. Furthermore, in combination they 
increased murine weight gain. The project also proved that the effect of TRIB3 knockout on 
weight was gender specific, as TRIB3-/- males on chow, weighed significantly more than 
C57B6 mice but this effect was not observed in females. TRIB3 may also increase cell mitosis 
of murine adipose tissue on HFD. In addition to this, the results confirmed what has previously 
been published with regards to TRIB3 maintaining normal blood glucose level. TRIB3 was 
also able to control lipid homeostasis and this is a novel discovery, as knocking out TRIB3 
reduced cholesterol and HDL levels significantly in murine blood on HFD. A critical question 
raised by these results is whether TRIB3 can be used as a treatment for insulin resistance, 
inflammatory and metabolic diseases. Further studies on TRIB3 need to be conducted to 
evaluate its multiple-functions, for instance molecular mechanisms of its action on signaling 
pathways, leukocyte chemotaxis, lipid homeostasis and insulin sensitivity. 
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Chapter 1: Introduction 
 
1.1 Infection, inflammation and signal transduction 
Infectious disease is the pathological state resulting from the harmful colonisation of host cells 
by a pathogenic microorganism. Infection can lead to subsequent tissue injury, which at times 
may be fatal. Inflammation, however, is the response of the host to infection, injury or irritants, 
symptoms of which can be swelling, fever, and erythema. It is a protective attempt via a 
complex biological response of the organism and initiates tissue healing processes. 
Acute inflammation represents the initial response to detrimental stimuli by serving to deliver 
mediators of leukocytes and proteins to the injured site. The inflammatory response is 
propagated and matured by a cascade of biochemical events involving the local vascular and 
immune system, as well as different cells within the injured tissue. As the detrimental stimuli 
are removed, the host returns to a normal state. If the detrimental stimuli cannot be quickly 
removed, the consequence may be chronic inflammation. Chronic inflammation is recognised 
by prolonged low-grade damage to cells by the inflammatory process propagated through 
signal transduction. 
Signal transduction is a rapid process involving the binding of ligands and extracellular 
signalling molecules to plasma membrane receptors on the surface of the cell in order to 
stimulate intracellular processes. It requires multiple enzymes to carry out a sequential order of 
biochemical reactions inside the cell. The enzymes are activated by second messengers, which 
then activate a signalling system. Signal transduction leads to various effects including cellular 
proliferation and apoptosis [1], alterations in metabolic processes [2], the switching on and off 
of genes [3] and activation of transcription factors. Newly produced proteins or mRNAs will, 
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in turn, induce the expression of other genes, leading to a complex cellular response. Thus, a 
stimulus can lead to new groups of genes being expressed, promoting for example the 
recruitment of neutrophils, which will be discussed in depth further in the thesis, to sites of 
infection stimulated by the products of bacteria. A transcriptional program is often defined as 
the set and order of changes in gene expression that are stimulated in response to specific 
stimuli [4]. 
 
1.2 Development of atherosclerosis is driven by multiple factors, 
including inflammation, hyperlipidaemia and metabolic 
syndromes. 
Atherosclerosis is thickening of the arteries, which occurs when fatty substances such as 
cholesterol accumulate in the artery walls and build up plaques (hard structures). Later, plaques 
may obstruct the arteries and lead to further complications. Artery wall thickening frequently 
occurs with aging, as with age plaque increases, hence, narrowing arteries and causing further 
thickening.	  Plaque formation requires smooth muscle cells, leukocytes, diverse inflammation 
and immunity response, for example cytokines [5]. Lesion starts as a fatty streak then may 
become a plaque, which have a lipid core and a fibrous cap. 
Study by Cook et al in 2006 found that nitric oxide (NO) may have an essential role in the 
atherosclerotic pathogenesis [6]. Acute coronary syndromes and ischaemic stroke 
atherosclerotic are a consequence of rupturing a plaque leading to thrombosis with arterial 
obstruction. 
These 'vulnerable plaques' may be widespread and yet may not produce stenosis or ischaemia, 
therefore are an underlying threat. This type of plaque causes acute clinical presentations such 
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as acute coronary syndrome and cerebrovascular events, whereas a more stable and stenotic 
plaque will produce a more chronic clinical picture such as stable angina. These concepts of 
widespread and vulnerable plaques have implications for management, reinforcing the 
importance to treat cardiovascular disease (CVD).  
 
1.2.1 Lipid metabolism, inflammation and atherogenesis 
Lipogenesis involves conversion of acetyl CoA to fat, which is then stored in the body. Fat is 
then broken down to produce energy either when the glycogen store is depleted or during 
starvation when there is no readily available glucose. Excess fat in the body leads to 
hyperlipidemia.  
Hyperlipidemia and inflammation are considered as risk factors for atherosclerosis 
development [7]. This section will show interactions between dyslipidemia and inflammatory 
processes leading to atherosclerosis development. Atherogenesis commences with 
inflammatory cell recruitment to the tunica intima [8]. Activation of endothelial cells leads to 
expression of leukocyte adhesion molecules, which cause monocytes to adhere to the intima. 
This results in the expression of scavenger receptors, allowing the uptake of modified low-
density lipoprotein (LDL). Cholesterol deposits result in collections of lipid-laden macrophages 
that form atheromatous plaques. These macrophages produce reactive oxygen species, pro-
inflammatory mediators, and tissue factor pro-coagulants that augment local inflammation and 
encourage thrombotic complications [9]. 
Various studies indicate that neutrophils (the first white blood cell (WBC) that migrates to the 
location of inflammation) may have an essential role in human atherosclerosis. Diverse lines of 
evidence have demonstrated a relationship between increased circulating leukocytes and high 
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cardiovascular risk [10], [11]. In this situation, neutrophils predominate [12]. Moreover, 
circulating neutrophils have been shown to be activated in a number of conditions associated 
with increased risk of atherosclerosis, for example type II diabetes [13], hyperlipidemia [14], 
obesity [15], HBP (high blood pressure) [16], smoking-dependent vascular inflammation [17]. 
Naruko et al reported that in acute coronary syndromes the predominance is for neutrophils in 
human lesions [18] and Zernecke et al in 2008 have published supporting evidence on the 
importance of neutrophils in developing atherosclerotic lesions in mice [19]. Baetta et al in 
2010 showed neutrophils could cause atherogenesis and atheroprogression [20]. Therefore, 
increased circulating neutrophils are a familiar marker for predicting cardiovascular events, 
regardless of disease status. 
  
1.2.2 Interactions between inflammation and lipid metabolism 
High circulating levels of modified lipoproteins (chylomicrons, very-low-density lipoprotein 
(VLDL) and LDL) trigger a hepatic inflammatory response through increased uptake by 
Kupffer cells [21], [22], promoting atherosclerosis. This is probably due to increased 
circulating proinflammatory mediators. Oxidized phospholipids promote endothelial cell 
dysfunction. Lysophosphatidylcholine (their derivative compound) may be involved in this step 
as they up-regulate metalloproteinase. Also oxidized phospholipids may be involved in 
atherosclerotic lesion progression, particularly those becoming vulnerable and unstable. 
Possibly, oxysterols and 4-hydroxy-2-nonenal have a main function in the inflammation-driven 
formation of atheroma. They are both critically implicated in foam cell formation via CD36 
scavenger receptor net overexpression and in up-regulating macrophage–smooth muscle cell 
cross talk, essentially via an overexpression of the transforming growth factor-β (TGF-β) 
profibrogenic cytokine. Interestingly, cholesteryl linoleate oxidation product 9-oxononanoyl 
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cholesterol seems able to increase TGF-β and TGF-β receptors steady-state levels in 
macrophage lineage cells. Oxysterols, and potentially other free aldehydic products for instance 
4-hydroxy-2-nonenal have a fundamental function in the process resulting in atherosclerotic 
plaque instability and rupture due to their ability to up-regulate macrophage metalloproteinase-
9 expression and activity, as well as their noticeable proapoptotic influence. In comparison, 
constitutive levels of tissue inhibitor of metalloproteinase 1 (TIMP-1) and TIMP-2 (its 
particular inhibitors) are not changed. Furthermore, arachidonic acid oxidation derivatives have 
major functions in vascular tone modulation and vascular remodeling, essentially by 
controlling cell proliferation, platelet function, and matrix deposition [22]. Activation of 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) in hepatocytes enhances 
atherosclerotic lesion development considerably [23]. Also increased levels of plasma serum 
amyloid A (SAA) post feeding of cholesterol is accompanied with atherosclerosis [24]. 
Vascular inflammation as mentioned in 1.2.1. can also be induced by these lipoproteins [25].  
In mice, hypercholesterolemia decreases binding and survival of regulatory T-cells in vessel 
wall, which disturbs the balance between T-cell subsets, resulting in a proinflammatory 
atmosphere locally [26]. A decrease in plasma cholesterol level restores the imbalance [26]. 
The content of macrophages found within plaque is also modified and the activity of hepatic 
and aortic NFκB and plasma SAA levels are reduced [27]. Furthermore, high-density 
lipoprotein (HDL) may be involved in decreasing vascular inflammation (as it has an anti-
inflammatory function) and decreases the expression of vascular cell adhesion molecule 1 
(VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) in aortic wall of rabbits [28].  
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1.3 Cellular and molecular aspects of vascular inflammation 	  
1.3.1 Neutrophils 
Neutrophil granulocytes are an essential part of the immune system [29]. Representing 40-75% 
of leukocytes, they are the most abundant circulating WBC in humans with a standard normal 
range of 2.5–7.5 x 109/l, around 1:1000 of the erythrocyte concentration. They are small cells, 
approximately 9-10 µm in diameter with a nucleus composed of 2-5 lobes. They contain lots of 
storage granules in the cytoplasm and very few mitochondria. They use glycogen from which 
they derive almost all of their energy. These types of cells are terminally differentiated with a 
lifetime of 5.4 and 0.75 days in human and mice circulation respectively [30]. Neutrophil 
derives its name from the ‘neutral’ pink stain obtained on H&E (hematoxylin and eosin) 
staining.  
 
1.3.2 Phagocytosis 
Neutrophils internalise foreign substances or microorganisms, as they are phagocytic, forming 
a phagosome into which hydrolytic enzymes and reactive oxygen species are released. 
“Respiratory burst” has been used as a term for the consumption of oxygen during the 
production of these reactive oxygen species, although this term is not directly related to energy 
production or respiration per se. However, whilst phagocytosis of pathogens by neutrophils is a 
fundamental step in host defence, it contributes to tissue damage when overwhelmed.  
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1.3.3 Leukocyte adhesion cascade 
Leukocyte margination (extravasation) from the blood vessels into inflamed tissue requires 
multi-adhesive stages. The process comprises: capture, rolling, slow rolling, firm adhesion and 
transmigration [31]. The principle mode of action of this cascade is displayed in figure 1.1.  
Capture or tethering and rolling are the initial contact between a leukocyte and the activated 
endothelial cells. It occurs after extravasation during the inflammatory response when the 
endothelium is activated [32].  Selectins and their ligands are largely mediating the capture step 
[32]. 
While E- and P-selectins are expressed by activated endothelium, the L-selectin is expressed on 
most leukocytes. Further to the interaction that occurs between L-selectin and endothelial 
selectins, the P-selectin glycoprotein ligand-1 (PSGL-1) expressed on leukocytes is an essential 
ligand of the 3 selectins. The binding of PSGL-1 with P- and E-selectins contributes to the 
leukocytes-endothelium interaction, whereas the binding of PSGL-1 with L-selectin assists in 
leukocyte-leukocyte interaction [33]. Furthermore, there are other glycoproteins for example 
CD44 or E-selectin-ligand-1 (ESL1) that can bind to selectins, in the case of E-selectin. For 
initial leukocyte capture PSGL-1 is required, while ESL1 is required for the conversion to 
slower and more stable rolling [34]. Eventually, CD44 regulates the rolling speed and 
intervenes in the PSGL-1 and L-selectin polarization [34]. 
Selectins stimulate different signalling cascades such as MAPK (Mitogen-activated protein 
kinase) or Ras pathway [35]. In addition, PSGL-1 stimulates various signalling cascades, 
leading to an increase in the expression of diverse molecules which may have a role in the next 
stage of the margination [36]. 
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Rolling slows down the flowing leukocytes [37]. Binding between the E-, P- or L-selectin and 
their ligands for instance PSGL-1 mediates the temporary rolling interactions between 
leukocytes and activated endothelium [37]. In addition to the capture and rolling, slow rolling 
requires P-selectin-PSGL-1 and E-selectin-PSGL-1 interactions [38], [39]. 
In slow rolling, integrins in particular β2-integrin lymphocyte function antigen-1 (LFA-1) 
promote firm adhesion from rolling [40], [41]. Signals from chemokines convert the low 
affinity selectin-dependent interaction to high affinity integrin-mediated firm arrest of 
leukocytes to the activated endothelium [42] for example cluster of differentiation molecule 
11B (CD11b) also known as macrophage-1 antigen (MAC-1), leukocyte integrin, interacts with 
the immunoglobulin superfamily ICAM-1, its corresponding endothelial receptor [43], [44]. 
Following firm arrest, leukocytes crawl on the endothelium utilising MAC-1 and LFA-1 
integrins [45] until they find a suitable place for transendothelial migration. This occurs either 
in a transcellular (via the endothelial cell body) or a paracellular (at the intercellular 
connections) fashion [46], [47]. The reason for the use of one pathway over the other remains 
unclear. The preference could be related to the level of the endothelium proinflammatory 
stimulation [48].  
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Figure 1. 1: Neutrophil adhesion cascade for chemotaxis 
Neutrophil response to chemoattractants released by microbes or other cells of the immune system are required to 
pass through the stages of the adhesion cascade (capturing from flowing blood, rolling, slow rolling and then 
adhere firmly to the endothelial cells before transmigrating through blood-vessel walls) to migrate to the site of 
infection or damaged tissues. These stages occur by expressing particular adhesion molecules on the surface of 
neutrophil and endothelial cells. 
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1.3.4 Chemotaxis 
Chemotaxis is a directional movement of inflammatory cells, such as neutrophils, in response 
to a chemical stimulation.  
Neutrophils, through their cell membrane receptors, are capable of recognizing chemical 
gradients of materials such as C5a and IL-8 (CXCL8), which act as attractants. These cells 
rapidly aggregate at infected and injured sites, due to being highly mobile, attracted by 
chemokines that are expressed by mast cells, macrophages, epithelium and endothelium when 
activated. It has been shown that neutrophils react during the first hour after damage to the 
body. These are the classic characteristics of acute inflammation. Neutrophil cells are attracted 
to bacterial and endogenous chemoattractant signals. First of all, upon cell damage and/or 
infection, neutrophils stick to endothelial cells in response to the presence of chemokines at the 
endothelial interface. Next, they move out of the vessels attracted by other chemokines, which 
are secreted by nearby macrophages and other serosal cells [49], [50]. Then neutrophils follow 
end target chemoattractants, complement molecules and bacterial fragments, once in the 
vicinity of the infectious place. It has been noted that neutrophils face lots of chemoattractants 
on the way and the existence of a hierarchy of chemokines seems logical. Certainly, it is true 
that in the presence of many different chemoattractants, these cells give priority to end target 
chemoattractants like N-formylmethionine leucyl-phenylalanine (fMLP) and C5a which 
emerge from infected sites, rather than to intermediary chemoattractants such as leukotriene B4 
(LTB4) and IL-8 which occur on the path to sites of infection even at high levels of 
intermediary chemoattractants [49], [51], [52], [53], [54].  
Under agarose assays have shown that end target chemoattractants work essentially by 
activating the p38 MAPK pathway. However, the PI3K (Phosphatidylinositide 3-kinase)/Akt 
(also known as Protein Kinase B, PKB) cascade works alongside intermediary 
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chemoattractants [49]. In the presence of competing end target and intermediary 
chemoattractants, neutrophils show considerable reduction of Akt activation. Since activation 
of the p38 MAPK cascade inhibits the PI3K/Akt cascade in neutrophils, these processes 
confirm the hierarchical dominance of end target chemoattractants over intermediary ones. The 
preferential trafficking of these cells towards end target chemoattractants occurs even at 
1/1000th of intermediary signals [49]. End target molecules do not need chemotactic 
characteristics, because LPS (lipopolysaccharide, p38 MAPK activator) inhibits Akt and 
consequently prevents movement to intermediary chemoattractants. On the other hand, p38 
MAPK inhibitors have been observed to make cells have a preference for migration towards 
intermediary chemoattractants rather than towards end target ones (because inhibition of p38 
MAPK leads to a notable increase in the activity of PI3K/Akt). Consequently, this leads to the 
drawing out of neutrophils from a location of end target chemoattractant surroundings to 
intermediary ones [49]. The receptors for chemoattractants are the seven-transmembrane helix 
receptor family [55], [56], although these chemoattractants have various structures. It has been 
shown that these receptors, once activated, broadcast signals to G proteins that lead to fast 
cytoskeletal rearrangements and chemotaxis via activation of downstream processes [57].  
Activation of the PI3K cascade is one of the most important processes of neutrophil 
chemotaxis [58]. Chemotactic receptors use the p110γ isoform (despite isoforms of PI3K being 
multiple) for downstream actions, which include formation of phosphatidylinositol 3,4,5-
triphosphate (PIP3) from membrane phospholipid phosphatidylinositol 4,5-biphosphate (PIP2). 
This leads to the activation of Akt, by phosphorylation. This is demonstrated by the defects in 
chemotaxis, which occur in p110γ deficient mice, induced by chemotactic receptor activation, 
showing neither phosphorylation nor activation of Akt [49]. Certainly, in humans and mice the 
p38 MAPK has a very necessary function in the chemotaxis of neutrophil cells [59], [60]. This 
process remains activated in p110 deficient mice, which may explain the accumulation of 
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neutrophil cells at the site of inflammation [61]. However, various aspects related to these 
pathways are still vague, such as if the p38 MAPK and PI3K/Akt cascades are overlapping, 
opposing or complementary to each other [49]. 
 
1.3.5 Neutrophil apoptosis 
A balance of intracellular death and survival cascades controls neutrophil apoptosis and 
determines neutrophil fate. Neutrophils undergo apoptosis even in the absence of extracellular 
stimuli. This is named spontaneous/constitutive programed cell death. Under most conditions, 
pro-survival and pro-apoptosis cues are received by neutrophils. The balance of these signals 
seems to detect the net influence [62]. 
Neutrophils are fast recruited to infectious/injured sites. They have a role in initiation and 
progression of the inflammatory response. In addition to their several defence mechanisms that 
destroy pathogens, they are also able to make damage to the surrounding tissue [29]. 
Neutrophils are supposed to go through constitutive apoptosis, once the pathogens are removed 
[63]. Apoptosis makes neutrophils not respond to extracellular stimuli, resulting in expression 
of “eat-me” signals. Therefore, they can be recognized and removed by macrophages in the 
spleen, bone marrow and Kupffer cells in the liver [64], [65], [63], [66], hence restricting their 
potentially detrimental effects. 
 
1.3.6 Neutrophils and vascular disease  
It has been observed that after ischemic injury, neutrophils play a role after myocardial 
infarction [67] and cerebral ischemia [68]. There is evidence of a pathogenic function for 
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neutrophils. Within a day of symptom onset, they accumulate at sites of ischemia in the brain 
[68]. However, in myocardial infarction they also promote healing and scar formation as they 
play an essential role in myocardial ischemia–reperfusion. Initiation of the inflammatory-like 
response occurs through interactions between adhesion molecules on neutrophils and coronary 
vascular endothelium. Organic NO-donor agents that interdict neutrophil responses may be 
cardioprotective [69]. It is also noted, that there is a strong correlation between the risk of acute 
myocardial infarction and peripheral-blood neutrophil count [70]. Sleep restriction predisposes 
to cardiovascular disease as it increases WBC counts, mainly neutrophils [71]. 
In the various intermediate and advanced stages of atherosclerosis, the existence of neutrophils 
has been noted. In atherosclerotic lesions, neutrophils adhere to the lesional cap and in the 
adventitial layer [72]. Activation of neutrophils might lead to platelet activation and 
subsequently cause thrombosis in coronary arteries with atherosclerosis [67]. In addition, a 
study published by Tuttle et al suggested that platelets and neutrophils have a greater chance of 
being activated in diabetic women than diabetic men. They may play a role in 
thrombosis/inflammation and the severity of coronary heart disease [73]. It has also been 
observed that platelets [74] and neutrophils [75] are activated during cardiopulmonary bypass 
(CPB). It has been proposed that hyperinsulinaemia might accelerate atherosclerosis by directly 
stimulating neutrophil migration through MAPK activation [76].  
The involvement of neutrophils in vascular diseases has been outlined above. Possible 
contribution of neutrophils in atherogenesis has been highlighted.  However, as neutrophils 
also promote healing in myocardial infarction, it may be possible to utilise this function for 
treatment purposes. 
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1.4 Signalling pathways 	  
1.4.1 Signal transduction mediated by mitogen-activated protein 
kinase (MAPK) cascade 
The MAPK cascade represents one of the major signal transduction pathways that respond to 
extracellular stimuli such as mitogens (chemical substances that trigger mitosis causing cell 
division), and then controls diverse activities of cells, for example cellular proliferation [77], 
gene expression, growth, mitosis, differentiation, inflammatory responses, chemical and 
physical stress and cell survival/apoptosis [78]. On the other hand, the MAPK cascade is dys-
regulated in various diseases, such as cancer, inflammatory, and immunological disorders. 
Therefore, it is an important target for therapy [77]. 
It has been recognized that mammalian cells have at least 14 genes encoding for mitogen-
activated protein kinase kinase kinases (MAPKKKs), seven mitogen-activated protein kinase 
kinases (MAPKKs), and 12 MAPKs [77]. ‘MAPK cascade’ refers to any three kinase cascades 
activated by sequentially phosphorylating each other in response to various stimuli. For 
example, stress on a cell, growth factors, adherence of a cell, neurotransmitters, and cytokines 
can all lead to a diverse range of physiological responses. 
Generally, the scheme of the MAPK cascade is composed of three kinase/phosphatase cycles, 
constructed into a three-tiered pathway. This pathway consists of a MAPK activated through 
phosphorylation by a MAPKK/MKK, which is phosphorylated by a MAPKKK/MKKK [79]. 
However, MAPKs are inactivated by a phosphatase family called MAPK phosphatases (MKPs) 
[80], [79], which plays an important role in regulation of MAPK through a phosphorylation 
cascade [81].  
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It has been documented that most MAPK cascade stimulators begin signalling by stimulating 
cell surface receptors that congregate into a receptor signalling complex. Then they activate a 
MAPKKK through a small GTPase [79]. The signalling process within the MAPK-cascade 
module seems to be fairly specific, which is common with a linear structure. However, there is 
a large body of literature demonstrating cross talk between the different MAPK pathways. For 
instance, it has been proposed that during apoptosis extracellular signal-regulated kinase (ERK) 
pathway activity is suppressed by c-Jun N-terminal kinase (JNK)/p38 kinases [82]. The number 
of MAPK effectors is vast and varied, including protein kinases, cytoskeletal proteins, and 
transcription factors. As a result of activation, MAPK can translocate into the nucleus and 
regulate gene transcription via its effect on the structure of chromatin and modifying of 
transcription factor activity [83], [79]. 
MAPKs have been uncovered as the essential regulators of pro-inflammatory cytokines, 
controlling, for example, the production of IL-1, IL-12, and tumor necrosis factor (TNF). In 
addition, MAPKs play very important roles in signal transduction pathways through the T-cell 
receptor/cluster of differentiation 28 (TCR/CD28) and toll-like receptor (TLR), B cell antigen 
receptor (BCR), and IL-1, IL-17, and TNF-α receptors [84], [85], [86] and chemoattractants 
(eg. fMLP) [49]. 
MAPK cascades have been studied widely, from yeast to humans. It has been discovered that 
there are three MAPK families in mammalian cells [77], [87]: 
• Classical MAPK, known as ERK.  
•  JNK/SAPK (stress-activated protein kinase). 
• P38 MAPK. 
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Cross talk between MAPK pathways are illustrated in the following figure, which demonstrates 
the essential components of these processes. 
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Figure 1. 2: Cross talk between different MAPK pathways 
Activation of MAPKKKs leads to the phosphorylation of MAPKKs and ultimately to the activation of three 
MAPK families; extracellular signal-regulated kinase (ERK), C-Jun N-terminal kinase/stress-activated protein 
kinase (JNK/SAPK), and P38 MAPK. The MAPK cascades regulate diverse cellular, physiological and 
developmental processes, including apoptosis and differentiation. Red arrows are to show the crosstalk. 
Stimulus                     hyperosmosis, oxydative stress, 
                              UV radiation, inflammatory cytokines 
 Response            apoptosis, inflammation, growth/cell 
                                 cycle arrest, cell differentiation 
   
 MKKK                    MEKK1/4                       MLK1/2/3 
                                     ASK1/2 
  MKK           MKK3/6              MKK4                MKK7 
                             
 MAPK                      P38α/β/γ/δ           JNK1/2/3 
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1.4.1.1 ERK cascade 
The Raf-MEK-ERK cascade is one of the most well-documented MAPK signalling pathways. 
It has been reported that the activation of receptor tyrosine kinases (RTKs) and tyrosine kinase 
receptors enhances the stimulation of these MAPKs [77]. For instance, signalling proteins 
linking epidermal growth factor receptors to MAPK activation contain guanine nucleotide 
exchange protein (an adaptor protein Grb2), a small GTP binding protein, Sos, p21ras, a 
sequence of protein kinase cascades, involving MAPKKK, c-RAF-1, and MAPKK (for 
example MEK1 and MEK2). MEKs phosphorylate ERK1 and ERK2 (p44 MAPK and          
p42 MAPK, respectively), therefore increasing their activity [88], [77]. The activated ERKs 
enter the nucleus and fulfil various functions such as activation of transcription factors, altering 
gene expression to stimulate mitosis, differentiation or growth [77]. It has been observed that 
whilst the ERK pathway has a minor function in the microbicidal activity of neutrophils, it is 
essential in regulating the migration of neutrophils in response to fMLP [89]. A further study 
by Katsube et al in 2008 found that activation of the ERK cascade in human neutrophils upon 
exposure to calpain inhibitors is followed by active migration of neutrophils (chemotaxis) [90]. 
 
1.4.1.2 JNK cascade 
JNK α, β, and γ are encoded by three genes with 12 conceivable isoforms [91], [77]. Many 
MAPKKKs stimulate the JNK family, including the ASK group, MLKs, the MEKK group, 
TAKI, and Tpl2 [92], [77]. JNK can interact with c-Jun through its NH2-terminal activation 
domain and phosphorylate it on Ser-63 and Ser-73. c-Jun/c-fos combination forms activating 
protein-1 (AP-1) transcription factor [93], [94]. Therefore, it starts a positive feedback loop. 
There are different substrates for JNK, for instance NFAT4, DPC4, Elk-1, c-Jun, Sap-1a, p53, 
and activating transcription factor 2 (ATF-2) [95], [77]. As a result of activation of these 
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factors, there is an increased expression of c-Fos protein and a further increase in the level of 
AP-1. In addition, JNK phosphorylates JunB, JunD, and the Ets-related transcription factor 
PEA3 as well [96], [97], [77]. JNK stimulation is associated with proliferation, differentiation 
and apoptosis [77]. A study by Katsube et al reported that activation of the JNK cascade in 
human neutrophils upon exposure to calpain inhibitors is followed by active migration of 
neutrophils [90]. A further study by Kato suggested that JNK isoforms are involved in tumour 
necrosis factor α (TNFα)-induced neutrophil apoptosis and granulocyte-macrophage colony-
stimulating factor (GMCSF)-mediated anti-apoptotic effect on human neutrophils, as well as in 
TNFα-induced and GMCSF-induced superoxide release [98]. 
 
1.4.1.3 p38  
Stress on cells (including UV irradiation, high osmotic stress, heat shock, protein synthesis 
inhibitors), lipopolysaccharide, proinflammatory cytokines (for example TNF-α and IL-1) and 
specific mitogens activate the mammalian p38 MAPK families. At least four isoforms of p38 
have been discovered (p38α, β, γ, and δ). MAPKK SKK3 (MKK6) can phosphorylate all of 
these isoforms. However, some p38 isoforms can be phosphorylated by other MAPKKs. p38α, 
γ, and δ can be activated by MKK3, whereas only p38α can be activated by MKK4 [77]. p38δ 
is essential for Interferon (IFN) signalling, in which it directs both the phosphorylation and the 
activation of cytosolic phospholipase A2. It has been observed that IFNα or γ stimulation of 
p38 MAPK also leads to the phosphorylation of Ser 727 of the transcription factor Stat1 [99]. 
The transcription factors Growth Arrest and DNA Damage transcription factor 153 
(GADD153), Sap-1a, and ATF-2 can also be phosphorylated by p38 [100]. Moreover, NF-κB-
dependent transcription can be regulated by p38 after its entrance into the nucleus. 
Interestingly, specific p38 isoforms stimulate non-transcription factor targets like the 
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MAPKAPKs (mitogen-activated protein kinase-activated protein kinases), -2, -3 and -5 and 
MNK1 (MAPK-interacting kinase 1), a related protein. P38 MAPK has a number of roles in 
inflammation, proliferation, differentiation, development, survival, apoptosis, as well as stress 
responses [77]. Katsube et al reported that activation of the p38 cascade in human neutrophils 
upon exposure to calpain inhibitors is followed by active migration of neutrophils [90]. In 
addition, previous findings demonstrated that in human neutrophils Myeloid-Related Protein-
14 (MRP-14) is a potential mediator of p38-dependent functional responses [101]. 
Furthermore, a study by Browning et al examined the effects of NO on human neutrophils in 
the stimulation of p38 by LPS found that NO is sufficient to cause an increase in 
phosphorylation of p38 [102]. 
 
1.4.2 Signal transduction mediated by phosphoinositide 3-kinase 
(PI3K) cascade 
The lipid kinase, PI3K, is a family of enzymes organized into 3 classes [103]; class I (catalytic 
p110 subunits and p85 adaptors) [104], class II (>200 kDa, characterized by a C-terminal 
containing a C2 domain) [104] and class III (homologous to the archetypal Vps34p 
characterized in Saccharomyces cerevisiae [104]. 
PI3K is activated by: 
• Diverse forms of cellular stress, for example swelling of the cell or oxidative stress. 
• Diverse hormones like insulin, platelet-derived growth factor (PDGF), epidermal 
growth factor  (EGF), hepatocyte growth factor (HGF), insulin-like growth factor  
(IGF) and nerve growth factor (NGF). 
• Ras activation.  
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• Signals coming from binding of receptors with the extracellular matrix molecules. 
• Chemokines; neutrophils prefer to migrate towards the intermediary chemoattractants 
via PI3K/Akt (as discussed earlier). 
This lipid kinase phosphorylates plasma membrane phosphatidylinositols, the 3rd OH group of 
the inositol [105], for instance generating PIP3 from PIP2. This PIP3 recruits protein kinases at 
the plasma membrane. These kinases like phosphoinositide-dependent kinase 1 (PDK1) and 
Akt bind with their pleckstrin homology-(PH)-domain to PIP3. Akt needs full activation 
through its phosphorylation at Thr-308 by PDK1 and at Ser-473 by PDK2 [106]. PDK1 further 
activates atypical protein kinase C (aPKC) and Serine/threonine-protein kinase (SGK), which 
alongside with Akt, phosphorylates a broad range of cellular signalling molecules that have a 
function in:  
• Cell growth regulation [107], cellular proliferation [107], cell cycle, including 
serine/threonine kinase (p70S6K), forkhead box protein O1 (FKHR), mammalian target 
of rapamycin (mTOR) and glycogen synthase kinase 3 beta (GSK3β). 
• Apoptosis, including mouse double minute 2 homolog (Mdm2), IκB, caspase 9 and 
FKHR. 
• Transport, including diverse channels and transports. 
• Chemotaxis (as described above). 
In addition, Akt further activates mTOR [108] which stimulates the uptake of nutrients 
including iron, amino acids, glucose and cholesterol. Phosphorylation of p70S6K is regulated 
by mTOR. PDK1 may similarly stimulate p70S6K. mTOR, in turn, further activates eIF4E-
binding protein-1 and is therefore involved in protein translation. 
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mTOR, DNA-dependent protein kinase, integrin-linked kinase or Akt itself via 
autophosphorylation have been proposed to act as PDK2 [109], [110]. mTOR is part of two 
diverse complexes, mTOR complex 1 (mTORC1) and mTORC2, which controls different 
proteins [111]. mTORC2 works upstream and is proposed to phosphorylate Akt, while 
mTORC1 works downstream of Akt [111]. There are studies proposed that variety in Akt 
signalling may in part be due to different roles of the three Akt isoforms Akt1/PKBα, 
Akt2/PKBβ and Akt3/PKBγ [112]. It has been indicated that Akt1 has a critical function in cell 
survival [113], [114], whereas another studies proposed Akt2 has a central role in the 
maintenance of glucose homeostasis [114], [115] and Akt3 function has been suggested in 
brain development [116]. Liu et al demonstrated that Akt1 is the dominant isoform expressed 
in neutrophils. Additionally, bacterial infection and neutrophil activation lead to downregulate 
this isoform [117], whereas Chen et al found Akt2 has the predominant role in modulating 
neutrophil functions and showed for the first time that Akt1 and Akt2 act differently in 
controlling main neutrophil functions [118]. Fischer-Posovszky et al found proliferation and 
adipogenic differentiation of human adipocytes is Akt2-dependent in preadipocytes, while 
Akt1 and Akt2 are equally important for regulating insulin-stimulated metabolic cascades 
[119].  
It has been found that inhibition of PI3K (by Wortmannin and LY294002) stimulated 
lipopolysaccharide (LPS)-induced coagulation, as well as inflammation which causes 
decreased survival of endotoxemic mice. Therefore, in endotoxemic mice, the PI3K-Akt 
cascade may suppress inflammation and coagulation [120]. It is also known that PI3Ks control 
phagocytosis. PI3Ks class 1 and 3 work consecutively in the production and maturation of 
phagosomes. Their products, PIP3 and PIP (phosphatidylinositol 3-phosphate), are assembled 
temporarily at various stages [121]. 
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The activation of PI3K occurs in response to the dissociation of Gα subunit from Gβγ subunits 
upon the binding of chemoattractants with G protein-coupled receptor (GPCR). PI3K then 
converts PIP2 to PIP3. PDK1 and Akt by their PH domain are recruited to the plasma 
membrane through binding to PIP3. PDK1 activates Akt by phosphorylation resulting in the 
activation of several other proteins responsible for a range of cellular functions (Figure 1.3). 
Published data indicated that PI3Kγ controls T cell activation, neutrophil migration, thymocyte 
development and the oxidative burst [61]. In addition, preceding findings proposed that platelet 
activating factor (PAF) causes intracellular alkalinisation through PI3K-MAPK activation. This 
influence in bovine neutrophils is upstream controlled by PAF receptor, pertussis toxin (PTX)-
sensitive G protein, tyrosine kinase, PI3K and MEK1/2 [122]. Furthermore, it has been 
published that PI3Ks and mTOR in the innate immune system integral players in coordinating 
defence mechanisms. Accordingly, in neutrophils and mast cells PI3K and mTOR positively 
regulate immune cell activation [123], as already alluded to in 1. 3. 4. 
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Figure 1. 3: Neutrophil migration by the PI3K/Akt signalling cascade 
In response to binding of chemoattractants with G protein-coupled receptor (GPCR) the Gα subunit dissociates 
from Gβγ subunits causing activation of PI3K. This results in the plasma membrane phosphatidylinositol-3,4,5-
trisphosphate (PIP3) being converted from phosphatidylinositol-4,5-bisphosphate (PIP2). Phosphoinositide-
dependent kinase 1 (PDK1) and protein serine-threonine kinase (Akt) recruit to the plasma membrane as their 
plackstrin-homology (PH) domains bind PIP3. PDK1 activates Akt by phosphorylation. The Activated Akt then 
phosphorylates other proteins to promote neutrophil migration. 
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1.4.3 Other inflammatory signal transduction pathways 
In addition to the signaling pathways introduced above, further signalling systems also play an 
important role in regulating inflammatory activation of cells. These pathways transduce a large 
variety of external signals, resulting in a wide range of cellular responses such as 
differentiation, growth, inflammation and apoptosis. The following pathways are just examples 
of many other pathways involved, although are not central to the background of this project.  
NFκB is a transcription factor possessing essential functions in several signalling cascades 
[124]. This transcription factor exists in an inactive form in the cytoplasm of the cell [125]. 
However, in response to various stresses like heat shock, inflammation, and infection [124], 
NFκB can be activated. Upon activation, this transcription factor translocates to the nucleus 
and promotes the expression of a number of genes [125], including proinflammatory cytokines 
and chemokines. NFκB has been associated with tissue repair as well as apoptosis [126]. It has 
been suggested that modulation of signalling actions which mediate activation of this 
transcription factor, may have an enormous potential in treating many disorders and also 
repairing tissue [127]. Furthermore, in case of neutrophil-mediated inflammatory disorders, 
Miskolci et al in 2007 demonstrated that NFκB is continuously activated in stimulated human 
neutrophils [128]. 
IFNs are cytokines produced by cells in response to pathogens like viruses, bacteria, parasites 
and tumors. IFNs are responsible for activating signal transducer and activator of transcription 
(STAT) complexes, which are transcription factors that control particular immune system 
genes expression by binding to their receptors. Jones et al in 2006 found during E. coli 
pneumonia, IL-6 has key roles in activating STAT1 and STAT3, enhancing recruitment of 
neutrophils and reducing bacterial burden [129]. 
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1.5 Tribbles (TRIBs)  
Recently, a family of signalling regular proteins, known as TRIBs have been identified as 
regulators of intracellular signalling pathways and a number of physiological processes 
including development [130]. In addition, TRIBs are thought to be involved in cancer and 
diabetes mellitus [130]. Through their unique action, TRIBs can co-ordinate activation and 
suppression of different interacting intracellular signalling processes. Therefore, these proteins 
seem to be essential in determining cell fate while responding to the challenges of the 
environment [131]. Eder et al in 2008 detected TRIB2 as a novel controller of inflammatory 
activation of monocytes [132], while Wei et al in 2012 demonstrated TRIB2 as a novel 
controller of TLR5 signaling cascade. Changed expression TRIB2 may have a role in 
inflammatory bowel disease (IBD) [133]. 
It has been recorded that there are different mechanisms for regulation of cell function. These 
include enzymes and regulator proteins that may not have a catalytic role; rather they join other 
proteins and then alter their function. Kinases, lipases and phosphatases are examples of 
catalytic signal transducers. The TRIB protein family seems to have an undetermined location 
in this classification. It is still unclear whether a signal kinase-like domain, which TRIB 
proteins have, has catalytic activity or not. A review by Dobens and Bouyain 2012 discussed 
TRIBs and found that they may function in some situations as active kinases and in others as 
passive adaptor proteins [134]. Furthermore, this protein family does not have the protein-
protein interaction domains, such as PDZ, SH2, and SH3 which represent a typical 
characteristic of adaptor/scaffold proteins, as well as several other kinases. Technically, lack of 
interaction domains and enzyme activity is very unusual, and very interesting, because there 
are a considerable number of interactions, positive and negative, between TRIB proteins and 
various signalling cascades in diverse cellular systems [130]. 
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With regards to the role of TRIBs in adipose tissue, a study by Ostertag et al in 2012 showed 
adipose tissue inflammation was regulated via TRIB1 [135], whereas Sung et al in 2012 
observed enhanced expression of TRIB1 in macrophage of experimental atherosclerotic mice 
[136]. 
Takahashi et al (2008) showed TRIB3 down-regulates PPAR-γ (peroxisome proliferator-
activated receptor-γ), a master controller of adipocyte differentiation, and regulates 
adipogenesis [137].  
Literature relating to the heart includes that of Ti et al (2011) who showed in the diabetic rat 
model TRIB3 gene silencing alleviates diabetic cardiomyopathy [138]. In addition to this 
Prudente et al in 2012 detected that TRIB3 has a role in mechanisms of metabolic and 
cardiovascular abnormalities in humans [139]. 
A review in 2012 by Angyal and Kiss-Toth summarised evidence showing that allelic variants 
of TRIBs were found associated with the regulation of fatty acid synthesis, insulin resistance, 
plasma triglyceride (TG) level and HDL cholesterol level. In addition, they discussed the 
importance of TRIBs in human disease [140]. 
 
1.5.1 Identification of TRIBs   
TRIBs proteins have been identified by three different methods: 
• The first method depended on the genetic features. These genes in diverse physiological 
circumstances were differentially expressed. It has been shown that in mitogen 
stimulated thyroids, canine TRIB2 is a differentially expressed gene [141]. In granulosa 
cells of chorionic gonadotropin, downregulation of bovine TRIB2 stimulated dominant 
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follicles [142]. During the death of a neuronal cell, rat TRIB3 was induced [143]. In a 
fatty liver dystrophy mouse, there was an altered expression of mouse TRIB3 [144]. 
• The second approach necessitated functional screens. This strategy identified human 
TRIB1 as a modulator of MAPK signalling cascades [145], [146], and Drosophila 
TRIB as an essential regulator of morphogenesis [147], [148].  
• The last strategy depended on interaction screens. Interactions between TRIBs and a 
wide range of signalling protein molecules, including Akt have been demonstrated 
[130]. 
 
1.5.2 TRIBs function in vivo 
The interactions between TRIBs and other protein molecules have been focused on in several 
studies. However, there is also emphasis on the roles of TRIBs in vivo. During morphogenesis 
in Drosophila, TRIBs regulate string [147], [149]. During oogenesis, this regulatory function 
was recognized in a diverse developmental setting as well. A set of highly specialized cell 
divisions is involved in this process; a number of which are regulated by expression levels of 
TRIB proteins [149]. Naiki et al (2007) found TRIB2 inhibits differentiation of adipocyte by 
suppressing Akt and CCAAT/enhancer-binding protein β (C/EBPβ) in mice [150]. TRIBs 
interaction with other proteins has also been demonstrated by Saka et al in 2004. They found 
that mitotic progression and nervous system development required a TRIBs orthologue in 
Xenopus [151]. Obviously, there are diverse experiments demonstrating an essential regulatory 
function for TRIBs in cellular regulation and development, although TRIBs’ role and 
molecular mechanism of action in signalling pathways are unclear as of yet [130]. 
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1.5.3 TRIBs interacting proteins 
Overexpressed TRIBs activated slbo ubiquitination. It has been observed that, for proper 
cellular behavior during morphogenesis, accurate regulation of slbo levels is needed. There is a 
suggestion that a key regulator of this pathway may be TRIB [152]. The interaction between 
TRIB1 and MAPKKs [145] have been recognized in the literature. There is a molecular 
association between MAPKKs and TRIB3, when overexpression in Hela cells takes place 
[145], likewise to TRIB1. However, TRIB3 is linked to MEK1 and MKK7 instead of MKK4. 
Nevertheless there is a suggestion of some functional specificity for these two members of the 
TRIBs family. The biological relevance of these results is still poorly understood and requires 
further studies [145]. It has been identified that TRIB2 proteins interact with overexpressed 
Akt [153]. The PI3K cascade activates a serine/threonine kinase, Akt, which plays an essential 
function in the cell, such as in the activation of the cell, cell division and apoptosis. Proteins 
that interact with an Akt1 mutant (which lacks the N-terminal PH domain) demonstrated in 
yeast two-hybrid system (Y2H) that TRIB3 is a binding partner [153]. In 239T cells, in a 
mammalian 2-hybrid assay, the interaction was verified showing that in Akt1, 240-315 aa are 
necessary for this interaction. In addition, it has been shown that in vitro translated TRIB3 
interacts with baculovirus expressed Akt1. Co-precipitation assay confirms interaction between 
endogenous TRIB3 and Akt, using HepG2 cell extracts (Hepatocellular carcinoma, human) 
[153]. There may also be an interaction between TRIB2 and ras homolog gene family, member 
B (RhoB) [154]. Koo et al in 2004 found TRB3 is a target for PPAR-α in liver as the induction 
of TRB3 promotes insulin resistance via peroxisome proliferator-activated (PPAR)-γ 
coactivator-1 (PGC-1) [155]. 
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1.5.4 TRIBs cellular localization 
There are many investigations showing different TRIBs intracellular localizations [130]. 
Interpretation requires caution as these are based on overexpression. Whilst these 
overexpressed proteins often imitate the localisation of endogenous genes, sometimes 
overexpression leads to experimental artefacts. Whilst the majority of signalling proteins work 
as part of multiprotein compounds, exorbitant amounts of individual parts may lead to 
abnormal intracellular localization. 
 
1.6 TRIBs, MAPK, and PI3K pathways 
Control of MAPK pathways is essential for regulating various cellular responses. Human 
TRIBs homologues (HTRIBs) organize MAPK activity. MAPK binds with TRIBs and controls 
the levels of their steady state. Moreover, this protein family, TRIBs, coordinates p38 MAPK, 
JNKs, and ERKs activation with diverse relative activity levels for the three MAPK categories 
according to TRIB expression level [145].  
It has been shown that a canine TRIB-2-like protein was reported as a very labile cytoplasmic 
phosphoprotein, mitogen stimulated and transiently expressed. However, its biological role is 
not fully understood [156], [141]. During apoptosis of nerve cells, rat TRIB is rapidly 
upregulated [143]. In the liver, TRIB3 controls Akt activation by insulin [153], as well as 
regulating the activity of activating transcription factor 4 (ATF4) [157], [158]. TRIBs bind to 
MAPKK and control the activation of MAPK. It has been recorded that TRIBs seem to play an 
important role in the MAPK cascade, but at high concentrations they inhibit this cascade. To 
explain these results, many mechanisms are hypothesised; for example, TRIBs could act as 
scaffolds [145]. MAPKKs conjugate TRIBs and stabilize them. TRIBs and TRIB mRNA are 
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rapidly stimulated by mitogen and have short half-lives [156], [141]. Therefore, these findings 
suggest that TRIB/MAPK interactions are dynamic and are under the control of extracellular 
signals. Furthermore, MAPK pathways are proposed to have a nonlinear behaviour due to 
incorporation of a positive feedback loop [159]. TRIBs might behave either as activators of 
MAPK activity or as inhibitors, according to the TRIB to MAPKK ratio in the cell. Similarly, 
TRIB mediated regulation of NFκB [160], [161], and the control systems of the cell cycle have 
been found [162]. 
TRIB3 has been implicated in the regulation of metabolic processes, the stress response and 
cell viability. It also has a role in a number of medical conditions such as cardiovascular 
disease, diabetes and insulin resistance [163]. It has been identified that Akt activation is 
negatively regulated by TRIB3 and that insulin stimulates expression of TRIB3. Depending on 
cell type, TRIB3 expression is stimulated by insulin, for example in the liver and adipocytes, 
but not in muscle and beta cells. Expression of TRIB3 by the insulin hormone inhibits Akt in 
Fao hepatoma cells [164]. Furthermore, expression of this type of TRIBs by insulin needs PI3K 
[164]. On the other hand, inhibition of Akt induces expression of TRIB3, while inactivation of 
the expression of protein kinase C, zeta (PKCτ) restrains expression of TRIB3 enhanced by 
insulin. Therefore, as a result, PI3K stimulates signals both positively and negatively to 
regulate the expression of TRIB3. It has been proposed that TRIB3 expression enhanced by 
insulin acts as an indicator for how the many signalling processes stimulated by insulin are 
balanced [164]. In addition, a study by Takahashi demonstrated that TRIB3 containing a kinase 
domain without enzymatic activity negatively regulates PPARγ transcriptional activities by 
protein-protein interaction [137].  
Further recent studies looked at the role of TRIB3 in metabolism. A study by Avery et al in 
2010 found that TRIB3 induction is an essential part of the endoplasmic reticulum stress 
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response in cardiac myocytes, in addition to TRIB3 antagonizes cardiac myocyte survival and 
cardiac glucose metabolism [165]. Reinforcing importance of TRIB3, Liu et al in 2012 points 
the finger at TRIB3 as a potent physiological controller of insulin sensitivity and nutrient 
metabolism under conditions lack and excess nutrient [166]. 
 
1.7 The role of TRIB3 in vascular inflammation, insulin signalling 
and lipid homeostasis 
Du et al proposed in 2003 that TRIB3 regulates insulin signalling through Akt in liver [153]. 
Contradictory results in rat hepatocytes demonstrate that TRIB3 overexpression has no effect 
on insulin signaling [167]. Qi et al in 2006 proposed the function of TRIB3 in lipid metabolism 
in the adipocyte, which is the interaction of TRIB3 with acetyl coenzyme A carboxylase (ACC) 
and with caspase recruitment domain-containing protein 16 (COP1) which results in ACC 
degradation [168]. A publication in 2008 by Takahashi et al reported that TRIB3 inhibits 
differentiation of adipocyte and accumulation of intracellular TG through suppressing 
PPARγ transcriptional activity [137]. Okamoto et al in 2007 recorded no changes occurring in 
TRIB3-/- mice compared to wild type (WT) littermates in glucose and lipid homeostasis, and 
insulin dependent signalling responses [169]. However, Weismann et al (2011) observed 
knockdown rats gained considerable weight, improved insulin sensitivity and increased PPARγ 
expression. Unexpectedly, Akt activation was not altered remarkably, which suggests TRIB3 
may regulate lipid synthesis through PPARγ mediated mechanism [170]. It is possible that 
TRIB3 controls signalling mechanisms modulating lipid metabolism, and TRIB3 dysfunction 
can lead to developing disease such as type II diabetes and metabolic syndromes. 
Literature looking at vascular inflammation include that of Wang et al in 2012 whom recorded 
that TRIB3 silence in diabetic apolipoprotein E (ApoE)-/-/LDL receptor-/- mice suppresses 
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atherosclerosis and stabilises plaques [171]. Furthermore, Andreozzi et al in 2008 found 
TRIB3 R84 variant is a more effective Akt inhibitor, thus in vitro impairs insulin signaling of 
human endothelial cells. This finding proposing TRIB3 R84 variant may contribute to genetic 
susceptibility to endothelial dysfunction and coronary artery disease [172]. 
A study by Prudente (2005) showed Q84R a human TRIB3 polymorphism reduced insulin-
induced Ser473-Akt phosphorylation in human HepG2 hepatoma cell lines. Results suggest 
that the TRIB3 gene has a function in human insulin resistance and related cardiovascular risk 
[173]. This proposes a possible link between TRIB3 and a chronic inflammatory disease. 
Given the above, it seems plausible despite the discrepancies in the literature to suggest TRIB3 
as an essential regulator of signalling mechanisms, controlling leukocyte function, glucose 
metabolism and lipid hemostasis. Furthermore, it has grown gradually based on laboratory data 
the dysregulation of TRIB3 function could be involved in human disease such as 
hyperlipidemia, type 2 diabetes, inflammatory and cardiovascular diseases. However, the 
mechanism by which TRIB3 contributes to such syndromes remains elusive. 
 
1.8 Hypothesis 
I hypothesize that neutrophilic inflammation may play a role in metabolic regulation via 
TRIB3. TRIB3 plays a key role in signalling pathways such as p38 MAPK and PI3K, which in 
turn may control neutrophil chemotaxis towards keratinocyte-derived cytokine, the murine 
homolog of GRO-α (KC) and fMLP. It is also possible TRIB3 may regulate the level of 
circulating glucose and lipid. 
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1.9 Aims of the project 
I. Determine the role of TRIB3 in neutrophil signalling cascade regulation in response to 
chemoattractants.  
II. Determine the effect of absence of TRIB3 on neutrophil function and chemotaxis. 
III. Determine the role of TRIB3 on neutrophilic inflammation. 
IV. Determine the role of TRIB3 in development of metabolic disease.  
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Chapter 2: Materials and methods 
	  
2.1 Materials  
The study involved the use of different materials including chemicals and other laboratory 
substances (appendix 1), equipment (appendix 2) and software (appendix 3). 
 
2.2 Methods 	  
2.2.1 Animals 
Mostly male C57B6 mice were used in wild-type animal experiments. Mouse supplier: Harlan 
UK (Bicester), work area: Biological Services Unit, University of Sheffield. TRIB+/- mice 
[B6;129S5-TRIB3Gt(OST324148)Lex/Ieg obtained from European Mouse Mutant Archive, 
EMMA; ID: EM-02346, LEXKO-1947] were back crossed with C57B6 for ten generations and 
were then inter-crossed to generate TRIB3 embryos. This line was developed using the 
OST324148 OmniBank® ES cell line from a sequence tagged gene trap library [174]. Briefly, 
the gene trap vector included a two expression cassettes. The first cassette encoded for a splice 
acceptor site, followed by a fusion protein of beta-galactosidase and neomycin, thereby 
disrupting transcription of the targeted mRNA. The second cassette encoded for a “diagnostic 
marker”, followed by a splice donor site and was used to determine the site of insertion for the 
targeting vector by 3’ RACE. Using this gene trap vector, the TRIB3 allele was targeted in the 
first intron. Exons 2-4 encode for the TRIB3 Open Reading Frame; insertion of the gene trap 
vector prevented the expression of the TRIB3 protein. TRIB3-/- mice were obtained from 
internal animal facilities. The TRIB3-/- mice are bred within the Barrier area at the Western 
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Bank site, all staff shower and change clothing to enter the Barrier area. All cages, bedding and 
diet is either autoclaved or irradiated into the unit and the mice are housed in M3 and RB3 
cages and bred in monogamous pairs. Both groups (C57B6 and TRIB3-/- mice) aged 6-18 
weeks but HFD experiment aged 18 week upon commencement. 
The University of Sheffield Ethics Committee and the Home Office Animals (Scientific 
Procedures) Act 1986 of the United Kingdom approved the experimental procedures listed 
below.  
 
2.2.2 Calculation of total leukocytes and neutrophils 
To calculate total number of blood leukocytes a 10 µl sample of blood was diluted (1:10) with 
3% acetic acid to lyse erythrocytes. In every four corner squares of a haemocytometer, cells 
were counted using x 10 objective (Labovert FS, Leitz). Therefore, the total numbers of cells 
was calculated as follows: 
Total cells = average cells in every quadrants x total volume x dilution factor x 104 
The total number of isolated neutrophils was calculated in the same way except that samples 
were not diluted in acetic acid. 
 
2.2.3 Isolation of murine neutrophils  
Mice were anaesthetized, with pentobarbital sodium 20% solution [JM Loveridge plc 
(Southampton)], 200 mg/ml, 100 µl/mouse, by an i.p. injection. The blood was collected by 
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cardiac puncture, using 1 ml insulin syringes (25 g x ½); syringes were heparinised before use 
to prevent clotting. 
Anti-coagulated blood was mixed with dextran solution (1.25 % dextran in saline solution) and 
erythrocytes were sedimented at room temperature for 30 minutes. The leukocyte-rich upper 
layer (composed of approximately 70% lymphocytes, 4% monocytes and 26% neutrophils) was 
retained and washed in cold washing buffer [phosphate buffer saline (PBS) mixed with 0.1% 
bovine serum albumin (BSA), pH 7.4] by centrifugation (300 x g, for 6 minutes) at 4 ˚C. Then 
the leukocytes were resuspended in 2 ml buffer, and a total number of leukocytes were counted 
as mentioned in 2.2.2.  
Leukocytes were then incubated for 30 minutes at 4 ˚C with a mixture of primary antibodies; 
anti-CD2 (1.5 µg/106 lymphocytes), anti-CD5 (2 µg/106 lymphocytes), anti-CD45R (10 µg/106 
lymphocytes), anti-F4/80 (2 µg/106 monocytes), and anti-CD115 (7.5 µg/106 monocytes), 
which bound surface markers of unwanted cells (lymphocytes, immature and mature 
monocytes). The concentrations of these antibodies were calculated according to the number of 
unwanted cells.  
Cold buffer was then added and excess antibodies washed out by spinning, 300 x g for             
6 minutes at 4 ˚C (this step happened twice). The different types of leukocytes were 
resuspended in 80 µl PBS and goat anti-rat IgG microbeads, 20 µl/107 cells, and then incubated 
for 15 minutes at 4 ˚C, mixing every 5 minutes. While leukocytes are incubated, the separation 
column was prepared by running cold buffer through column, as illustrated in figure 2.1. 
Unwanted cells were then eliminated by passing of the cell/bead suspension through a cold 
column exposed to a Midi MACS magnet (Miltenyi Biotec). Lymphocytes and monocytes 
marked with the magnetic microbeads were captured in the metallic matrix of the column and 
neutrophils were collected as eluate, spun (300 x g, for 6 minutes) at 4 ˚C and the supernatant 
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discarded. Residual erythrocytes were lysed by resuspension in 0.2% NaCl and inverted x 10 
(hypotonic lysis), then in 1.6% NaCl mixed with 0.1% glucose and inverted once (hypertonic 
rescue). Neutrophils were centrifuged (300 x g for 6 minutes) at 4 ˚C, washed and 
recentrifuged as before. Finally, neutrophils were resuspended in 1 ml buffer and counted.  
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Figure 2. 1: Magnetic separation of murine neutrophils 
Neutrophils and unwanted cells (lymphocytes and monocytes) were incubated for 30 minutes at 4˚C with primary 
antibodies, which bound the cell surface markers of unwanted cells. Secondary antibody coated magnetic 
microbeads attracted to the primary antibodies were added and the mixture incubated for 15 minutes at 4 ˚C. The 
unwanted cells were then dislodged by channeling of the cell suspension/bead mixture through a cold metallic 
matrix into a column attached to a MACS magnet. Lymphocytes and monocytes marked with primary and 
secondary antibodies coated magnetic microbeads were held in the matrix and neutrophils were collected in the 
eluate. 
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2.2.4 Activation of neutrophils by KC, fMLP and LPS  
Isolated murine neutrophils were stimulated by diverse stimuli. They were divided into four 
aliquots for stimulating at different times. Each aliquot was centrifuged and the pellet was 
resuspended in RPMI (medium). Neutrophils were incubated with a stimulus (10-6 M KC,     
10-6 M fMLP or 1ng/ml LPS) for 0, 15, 30 and 60 minutes at 37 ˚C. Following incubation, the 
samples were pelleted (300 x g) for 6 minutes and the supernatant discarded.  
 
2.2.5 Lysis of neutrophils  
Lysis buffer (1% Triton X-100, 50 Mm 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 100 mM sodium fluoride (NaF), 10mM ethylenediaminetetraacetic acid (EDTA),   
10 mM Napyrophosphate, 10% glycerol, 0.2 mM phenylmethylsulfonyl fluoride (PMSF),     
7% protease inhibitor and 2 mM sodium orthovanadate (Na3VO4)) was added to the pellets 
from the previous procedure. The cells were incubated with lysis buffer on ice for 20 minutes, 
mixing periodically. The samples were sonicated for 2 minutes then pelleted (at approximately 
20,000 x g, for 15 minutes) and the lysates (supernatants) saved for further analysis.  
 
2.2.6 Protein measurement 
The protein concentration of the lysates were measured using the Bio-Rad DC protein assay   
(a colorimetric assay), which is based on protein reaction with copper in an alkaline medium, 
followed by reduction of folin reagent by the copper-treated protein to produce blue-colored 
compound with absorbance 405-750 nm2. 
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Serial dilutions (2.0 mg/ml, 1.5 mg/ml, 1.0 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml, 
0.0625 mg/ml, 0.0315 mg/ml) were prepared from a BSA stock (2.0 mg/ml) using the lysis 
buffer. Standards (5 µl) were pipetted in triplicate into microwells, while samples only once. 
Then a cocktail of reagents [reagent A (an alkaline copper tartrate solution), reagent B (a dilute 
folin reagent), reagent C] was added. The microplate was incubated for 5-10 minutes at room 
temperature to develop the blue color. The mean values of the triplicate protein standards were 
calculated and a standard curve was drawn by Revelation Quickline software version 4.25 
(Chantilly, VA, USA). 
 
2.2.7 Western blot analysis of p38 MAPK & Akt isolated from 
murine neutrophils 
Active (phosphorylated) forms of p38 MAPK and Akt were evaluated by western blotting. 
Both protein samples (lysates) and a rainbow molecular weight (MW) marker were prepared by 
boiling for 5 minutes after adding 5x reducing agent. After preparation they were run in 30% 
SDS polyacrylamide gel electrophoresis (approximately 1 hour at 170 V), followed by 
transferring to a nitrocellulose membrane using Towbin transfer buffer (composed of 39 mM 
glycine, 48 mM Tris, 0.037% SDS and 20% methanol) by semi-dry electro blotting at 5 V for 
90 minutes. Subsequently, non-specific binding sites of the membrane were blocked with 
blocking buffer containing 5% milk/Tris-buffered saline (TBS) 0.1% Tween buffer (washing 
buffer) by incubating either for 1 hour at room temperature or overnight at 4 ˚C, and washed in 
the washing buffer several times. The protein was incubated for 2 hours at room temperature or 
overnight at 4 ˚C with primary antibodies, phospho p38 MAPK antibody and phospho Akt 
antibody, diluted 1:1000 or 3:1000 with washing buffer. Excess antibody was eliminated by 
washing the membrane 3 times for 15 minutes by washing buffer on a rotating platform for      
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5 minutes each. Then the membrane was incubated with a horseradish peroxidase (HRP) bound 
goat anti-rabbit secondary antibody for 1 hour at room temperature (diluted 1:2000 in blocking 
buffer). Again excess antibody was removed with washing buffer and the plate was placed on a 
rotating platform for 5 minutes. This was repeated five to six times to ensure all excess 
antibody was removed. Conjugated protein was then developed by chemiluminescent detection 
methods based on substrate luminesce when exposed to the enzyme on the secondary antibody. 
The light was detected by Amersham HyperfilmTM ECL (Fisher, Loughborough, UK) or 
alternatively by CCD cameras (GeneSnap from SynGene software, version 7.04) that take a 
digital image. Densitometry was performed using GeneTools software (SynGene, version 3.02) 
that quantifies the relative amount of protein and expresses it as absorbance. Antibodies were 
stripped for reusing the membrane to detect total p38 MAPK and total Akt, following the same 
steps except primary antibodies (p38 MAPK antibody and Akt antibody) were diluted 1:1000 
in BSA/washing buffer instead of the washing buffer alone. 
 
2.2.8 Neutrophil chemotaxis 
Upon completion of isolation, neutrophil chemotaxis was performed (within the least time 
possible) in a 96-well chemotaxis plate (Neuroprobe ChemoTx system). The plate is composed 
of small-sized wells, polycarbonate filter membrane with 3 µm pores and lid. These pores are 
enclosed by hydrophobic rings to hold the cell suspension on the filter (Figure 2.2). Relevant 
wells were filled with a total volume of 30 µl of buffer (RPMI supplemented with BSA) or 
chemoattractant at different concentrations (diluted to the required concentration in the buffer), 
being careful not to let air bubbles form. The membrane was placed over the bottom wells and 
secured in position with the corner pins. 30 µl of neutrophils at a concentration of 2 x 106/ml 
suspended in buffer were located onto the filters. Chemokinesis controls, to correct for random 
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movement of neutrophils, were performed by placing 30 µl of neutrophils resuspended in one 
of chemoattractant concentrations on the filters corresponding to wells containing the same 
chemoattractant concentration. Therefore, no concentration gradient could occur. The lid was 
replaced and the chemotaxis plate was incubated at 37 ˚C, 5% CO2 for 1 or 3 hours. After 
incubation the lid was removed and the remaining non-migrated neutrophils and buffer on the 
filter was carefully absorbed using cotton buds and the top surface of the filter was washed 
several times by 30 µl of buffer each time. The chemotaxis chamber was centrifuged for        
10 minutes at 300 x g to remove any adherent neutrophils on the underside of the filter 
membrane into the wells. The membrane was removed and cells were resuspended in the buffer 
or chemoattractant already present in the well. The number of migrated neutrophils was 
counted using a haemocytometer and the percentage of neutrophil migration was calculated. 
Chemokinesis controls were subtracted from each value. 
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Figure 2. 2: Chemotaxis plate (modified boyden chamber) to investigate neutrophil migration 
96 small-sized wells filled with buffer or stimuli with different concentrations. Polycarbonate filter membrane 
with 3 µm pores is needed for neutrophils. This membrane is positioned over the bottom wells and secured in 
place with pins in each corner. Neutrophils were placed onto the filter and a lid was covered. The incubation 
period was at 37 ˚C, 5% CO2 for 1 or 3 hours (human or murine, respectively). The chemotaxis chamber was then 
centrifuged for 10 minutes at 300 x g to spin any adherent neutrophils to the underside of the membrane into the 
wells. Finally, the number of neutrophils migrated towards different stimuli concentrations was counted. 
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2.2.9 The effect of inhibitors on murine neutrophil migration 
The effect of inhibitors on murine neutrophil migration was investigated using the procedure of 
neutrophil chemotaxis. In addition to this, murine neutrophils were incubated with 10 µM of 
each of p38 and PI3K inhibitors for 30 minutes at 37 ˚C in 5% CO2 before being loaded on the 
filter. The above inhibitors were prepared in dimethyl sulfoxide (DMSO), therefore, DMSO 
was added to both the control and to the neutrophils (final concentration 0.5%) which were 
prepared to check chemokinesis. 
 
2.2.10 FACSCalibur flow cytometry procedure 
One half of C57B6 and TRIB3-/- murine whole blood were pre-incubated with 10-7 M phorbol 
12-myristate 13-acetate (PMA) and the other half from each group were left unstimulated (PBS 
was added instead) for 15 minutes at 37 °C before adding the antibodies. Samples were 
aliquoted into 100 µl each, keeping a sample of unlabelled cells for reference on ice. Other 
samples were incubated with either fluorescently conjugated antibodies or their fluorescently 
conjugated isotypes, non-specific fluorescently conjugated antibodies, in order to check the 
specificity of each individual antibody. The following antibodies and their isotypes were used: 
PE anti-mouse PSGL-1 and PE rat IgG1, κ isotype control, PE anti-mouse L-selectin and PE 
rat IgG2a, κ isotype control and PE anti-mouse CD11b and PE rat IgG2b, κ isotype control. 
FITC anti-mouse Ly-6G for labelling neutrophils was added to all samples except the sample 
of unlabelled cells (where neither FITC anti-mouse Ly-6G nor antibodies were used). After 
mixing well, the samples were incubated for 30 minutes on ice. 2 ml of PGB (PBS containing 
20 mM glucose plus 1% BSA) washing buffer was added to the samples and centrifuged at  
300 x g for 5 minutes to wash off excess antibodies. Supernatants were discarded and samples, 
including unlabelled cell samples, were incubated with 2 ml of 1x Erythrolyse for 10 minutes 
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at room temperature then centrifuged at 300 x g for 5 minutes. Supernatants were discarded 
and the pellets were washed with a further 2 ml of washing buffer by centrifuging at 300 x g 
for 5 minutes. Again supernatants were discarded and then the cells resuspended in 200 µl of 
buffer. The samples were put on ice in the dark to reduce the loss of fluorescent signal, until 
they were analyzed by flow cytometry. 
Results were acquired using a FACSCalibur flow cytometer (BD Bioscience) equipped with 
CellQuest Pro software BD version 3.01 (Erembodegem, Belgium, Europe). 488 nm argon blue 
Laser excited the fluorochromes PE (phycoerythrin; emission FL2 BP 575/26 nm) and FITC 
(fluorescein isothiocyanate; emission FL1 BP 530/30 nm). The variety in granularity, size and 
fluorescence intensity led to various parameters being applied with murine neutrophils. Size 
was shown by forward scatter (FSC) and granularity shown by side scatter (SSC). In addition, a 
gate enclosing the population of study was used to eliminate other cells and any debris. Events 
captured were 5,000-10,000. Histograms were drawn to illustrate the fluorescence profile 
depending on the number of cells that displayed particular fluorescence intensity at a specific 
wavelength. The geometric mean of the cells of interest was measured.  
 
2.2.11 Procedure for the detection of p38 MAPK in RAW 264.7 
mouse macrophage cells 
The RAW 264.7 cultured cells were provided and plated at a density of 2.0 x 105 cells/well by 
a colleague. The medium, Dulbecco’s Modified Eagle Medium 1x (4.5 g/L Glucose and         
L-glutamine), was removed from each well. Cells were stimulated with either 10-6 M of fMLP 
or 50 ng/ml of LPS, diluted in fresh media, at specific timepoints: 0, 10, 20 and 30 minutes at 
37 ˚C in 5% CO2. Following stimulation the plate was put on ice, medium removed and cells 
washed using ice cold PBS before adding 150 µl ice-cold 1x lysis buffer plus 3mM PMSF. 
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Then the cells were scraped off the well and transferred to an eppendorf tube, incubated for    
20 minutes on ice before sonicating in an ice-cold water bath one time for 2 minutes. The 
samples were centrifuged (at approximately 20,000 x g, for 10 minutes at 4 ˚C) and the 
supernatants (cell lysates) collected for western blotting, which can also be stored at -80 ˚C. 
 
2.2.12  p38 kinase assay 	  
2.2.12.1 Preparing cell lysates 
Cell lysates (RAW 264.7 cell and murine neutrophil lysates) were prepared as detailed in 
section 2.2.5 and 2.2.11. 
Selective immunoprecipitation (IP) using immobilized phospho p38 MAPK (Thr180/Tyr182) 
monoclonal antibody (mAb) 
20 µl immobilized mAb bead slurry was added to each 200 µl cell lysates and incubated 
overnight at 4 ˚C with gentle rocking. 
 
2.2.12.2 Kinase assay 
Cell lysates-immobilized Ab were centrifuged at 4 °C (for 30 seconds at 14,000 x g). Then 
pellets were washed twice with 500 µL 1X cell lysis buffer then twice more with kinase buffer 
while on ice before suspending in 50 µl 1X kinase buffer, 1 µl 10 mM ATP and 1µl ATF-2 
fusion protein (kinase substrate). 10µM p38 inhibitor or vehicle control (DMSO) was added to 
the samples which will be incubated for different periods of times (0, 30 and 60 minutes) at   
30 °C. Reaction was terminated by 25 µl 3x SDS sample buffer, vortexed and then centrifuged. 
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2.2.12.3 Western immunoblotting 
Active (phosphorylated) forms of p38 MAPK were evaluated via detecting phospho ATF-2 
with western blotting. Protein samples (lysates) and a rainbow MW marker to verify 
electrotransfer were prepared by boiling for 5 minutes after adding 5x reducing agent to the 
marker. After preparation they were run with biotinylated protein marker to detect MWs in 
30% SDS polyacrylamide gel electrophoresis (approximately 1 hour at 170 V), followed by 
transferring to a nitrocellulose membrane using Towbin transfer buffer by semi-dry electro 
blotting at 5 V for 90 minutes. Subsequently, non-specific binding sites of the membrane were 
blocked with blocking buffer containing 5% milk/TBS 0.1% Tween buffer (washing buffer) by 
incubating for 1 hour at room temperature, and washed in the washing buffer three times for    
5 minutes each. The protein was incubated with gentle agitation overnight at 4 ˚C with primary 
antibody, phospho ATF-2 (Thr76) antibody, diluted 1:1000 with washing buffer. Excess 
antibody was eliminated by washing the membrane 3 times with washing buffer on a rotating 
platform for 5 minutes each. Then the membrane was incubated with a secondary anti-rabbit 
IgG, HRP-conjugated antibody and anti-biotin, HRP-conjugated antibody for the detection of 
the biotinylated protein ladder (diluted 1:2000 and 1:1000 respectively in blocking buffer) for  
1 hour at room temperature. Again excess antibody was washed 3 times for 5 minutes each on 
a rotating platform with washing buffer. Conjugated protein was then developed by 
chemiluminescent detection methods based on substrate luminescence when exposed to the 
enzyme on the secondary antibody. The light was detected by Amersham HyperfilmTM ECL 
(Fisher, Loughborough, UK). 
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2.2.13 Role of TRIB3 on murine neutrophil recruitment in 
thioglycollate-induced peritonitis 
C57B6 wild type (control) and TRIB3-/- mice received an intraperitoneal injection of 1ml of 
4% thioglycollate broth (4% thioglycollate powder in 0.9% w/v NaCl; autoclaved and aged for 
> 7 days, used for induction of localised inflammatory response). Five time points were taken 
for sample collection: at 0 hour triplicate (three samples each group) and at 2, 6, 24 and 48 
hours tetra (four samples each group) have been obtained. Blood was collected by cardiac 
puncture using 1 ml heparinised insulin syringes after anaesthetising mice with isofluorane. In 
addition, 5 ml of lavaging buffer (PBS, 0.1% BSA, 20 mM D-glucose (required to keep cells 
intact during cytospin) and 10 U/ml heparin (clumping was avoided) was injected i.p. into mice 
(using 5ml syringe and 21G needle) after cervical dislocation. Peritoneal lavage fluid was 
recovered and transferred to 15 ml tubes, using either same syringe or Pasteur pipette and kept 
on ice once collected. 
A capillary tube containing 10µl of blood was transferred to a microfuge tube containing 90 µl 
of 3% acetic acid (needed for lysis red blood cells). Total leukocytes were counted from both, 
blood sample in acetic acid and peritoneal lavage fluid, using disposable haemocytometers. 
Cytospins of lavage samples were performed in duplicate for each sample at 900 rpm for 6 
minutes (100 µl lavage fluid/cytospin, maximum 1 x 106 cells/ml lavaging buffer), fixed in 
methanol for 5 seconds (5 dips), air dried, stained using Diff-Quick and flushed with generous 
amounts of slow running tap water. Differential cell counts from cytospin of lavage 
microscopy slides were performed. The remaining blood was collected in EDTA blood 
collection tubes and centrifuged for 20 minutes at 250 x G, supernatant (plasma) then collected 
for lipid profile (required at least 100 µl). After counting the cell and cytospin preparation, 
peritoneal lavage fluid was centrifuged at 350 x g for 6 minutes and the supernatant stored      
at -80 °C for cytokine experiment. 
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Calculation of neutrophil content in lavage: 
Total number of cells in lavage = leukocytes number/ml x total volume lavage x 104 
(leukocyte numbers have been counted by a haemocytometer). 
Total number of neutrophils = total number of cells in lavage x neutrophil percentage. 
 
2.2.14 Blood plasma lipid profile method 
Blood plasma lipid profiles (cholesterol, TG and HDL) of both wild-type and TRIB3-/- mice 
were measured via enzymatic colorimetric test by the department of Clinical Chemistry at the 
Royal Hallamshire hospital Sheffield, using Cobas 8000 system from Roche. 
 
2.2.14.1 Cholesterol test principle 	  
 
 
 
                                                                (Roche Assay methodology, cobas c systems, 2010-12, V 3 English) 
 
 
 
2 H2O2  +  4-AAP	   +  Phenol                                           Quinone-imine dye [Red]  +  4 H2O Peroxidase 
Cholesterol esters  +  H2O                                           Cholesterol  + 	  RCOOH 
Cholesterol Esterase  
Cholesterol  +  O2                                          Cholest-4-en-3-one   + 	  	  H2O2 
Cholesterol Oxidase 
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2.2.14.2 TG test principle 	  
 
 
 
 
                                                                          (Roche Assay methodology, cobas c systems, 2009-06, V 1 English) 
2.2.14.3 HDL test principle 
Water-soluble complexes with LDL, VLDL and chylomicrons are selectively produced by 
dextran sulfate in the presence of Mg2+. These complexes are resistant to polyethylene glycol 
(PEG)-modified enzymes. 
 
 
 
 
                                                               (Roche Assay methodology, cobas c systems, 2009-07, V 1 English) 
2 H2O2  +  4-amino-antipyrine  + HSDA*  +  H
+
  +  H2O                   
                                                                   
                                                                                                            Purple-blue dye  +  5 H2O 
Peroxidase     
H2O2  +  4-aminophenazone  +  4-chlorophenol                    
                                                                  
                                                       4-(p-benzoquinone-monoimino)-phenazone [Red]  +  2 H2O  +  HCl 
Peroxidase  
Triglycerides 	  +  3 H2O                                          Glycerol  +  3 RCOOH 
	  Lipoprotein Lipase 
Glycerol  +  ATP                                           Glycerol-3-P  + 	  ADP 
Glycerokinase 
Mg
2+
 
Glycerol-3-P  +  O2                                           Dihydroxyacetone-P  +  H2O2 
Glycerol-P Oxidase 
HDL-cholesterol esters  +  H2O                                                     HDL-cholesterol  +  RCOOH 
PEG-Cholesterol Esterase 
HDL-cholesterol  +  O2                                                      Δ4-cholestenone  +  H2O2 
PEG-Cholesterol Oxidase   
*HSDA = Sodium N-(2-Hydroxy-3-Sulfopropyl)-3,5-DimethoxyAniline  
	   52	  
Colour intensities of the specific dyes formed in the tests are directly proportional to the 
cholesterol, TG or HDL-cholesterol concentrations and are measured photometrically.1  
 
2.2.15 Murine TRIB3 genotyping 	  
2.2.15.1 Ear clip lysis 
150 µl lysis buffer (EDTA, Tris-HCl and Tween-20) containing proteinase K (300µg 
proteinase K/ml lysis buffer) was added to mouse ear clipping samples and then incubated 
overnight at 55 oC. Samples were then vortexed briefly and incubated for 12 minutes at 100 oC 
to inactivate proteinase K. 600 µl of water was then added to each sample, vortexed briefly and 
stored at +4 oC. 
 
2.2.15.2 PCR and sample analysis 
The following PCR reaction mix was prepared in 0.5 ml eppendorf tube: 
DNA template    3 µl 
H2O      9 µl 
LTR-2     0.5 µl 
LEXKO-1947-3’    0.5 µl 
LEXKO-1947-5’    0.5 µl 
Biomix     2.5 µl 
Total                            26µl 
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The following PCR program was run: 
Step 1: 95 oC for 5 minutes 
Step 2: 95 oC for 30 seconds 
Step 3: 65 oC for 30 seconds                       40 cycles 
Step 4: 72 oC for 30 seconds 
Step 5: 72 oC for 5 minutes 
Step 6: 10 oC hold 
A 1% agarose gel was prepared in 1x TAE buffer (Tris, acetic acid and EDTA) containing final 
ethidium bromide (EtBr) concentration of 1µg/ml. Electrophoresis was then carried out at 90V 
for approximately 40 minutes. Visualisation of PCR bands was then carried out under UV 
illumination (Chemi Genius2 Bio Imaging System using GeneSnap version 7.04) (Syngene).  
 
2.2.16 Effect of TRIB3-/- on embryo viability 
TRIB3+/- mice were backcrossed onto a C57B6 background for 10 generations. The genotype 
of the 10th generation (80 mice; 40 from each gender) from heterozygote mating was checked 
by PCR and produced a ratio of 17:39:24; C57B6, TRIB3+/- and TRIB3-/- mice respectively. 
This means TRIB3-/- mice represent 30% of the population, which approximately follows 
Mendel’s Law. According to this ratio knocking out TRIB3 from cells has no effect on 
breeding in this strain of mice. 
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2.2.17 Cytokine level measurement  
The BD cytometric bead array (CBA), a flow cytometric based application was used to 
measure diverse cytokines (GMCSF, IL-4, IL-13, IL-17A, KC, monocyte chemotactic   
protein-1 (MCP-1), MIP-1α, MIP-1β and TNF) simultaneously in peritoneal lavage fluid. The 
set of cytokine specific antibody-coated beads of the kit was applied to capture surface for 
cytokines of lavage supernatants. Each bead in the array has distinct fluorescence intensity for 
each cytokine. Therefore, beads were mixed and run together in one tube. The detection 
reagent delivers a fluorescent signal in proportion to the quantity of bound cytokine. Sandwich 
complexes (capture bead + standards/unknown samples + detection reagent) were measured, 
using flow cytometry to detect particles with fluorescence characteristics of the bead and 
detector. The bead population was resolved in two fluorescence channels of a flow cytometer. 
This work was carried out by the university Flow Cytometry Core Facility. 
 
2.2.18 Feeding of TRIB3-/- and control mice a high fat diet (HFD) 
 
Diet Name: RM AFE 60%FAT 20%CP 20%CHO (M) 25kGy 
Diet             824054 - '60% AFE Fat' 
Ingredient                               g% (w/w) 
Casein 29.944 
Choline Bitartrate 0.334 
L-Cystine 0.450 
Lard 29.248 
Rice Starch 10.079 
	   55	  
Cellulose 6.964 
Soya Oil 4.875 
Sucrose 11.838 
Minuteeral Mix 4.875 
Vitaminute Mix 1.393 
Special Diet Services (SDS, Witham, UK). 
 
2.2.18.1 Diet 
C57B6 and TRIB3-/- mice were fed 60% HFD (see above table for diet name, ingredients, 
amounts and company details) 5 g/mouse daily for 11 weeks. Also a further two groups 
(C57B6 and TRIB3-/- mice) were on chow (Teklad Global 18% Protein Rodent Diet, Harlan, 
UK). 
 
2.2.19 Weight gain 
C57B6 and TRIB3-/- mice were males and aged 18 weeks upon commencement of feeding. 
The weight was measured once weekly for 11 weeks, initiating with a baseline weight before 
feeding. 
 
2.2.20 Whole blood differential count (week 5) 
The blood was collected from the tail of C57B6 and TRIB3-/- mice at week 5. A cell counting 
machine (Sysmex KX-21N; Sysmex Corporation) was used to calculate differential blood cell 
types of both groups. 
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2.2.21 Glucose tolerance test (GTT) 
C57B6 and TRIB3-/- mice were starved overnight at week 9. Next day each mouse was 
weighed as glucose dose depends on its body weight (BW). Blood was then collected from the 
tail to determine a baseline glucose reading using glucose meter and strips. The mouse was 
then injected intraperitoneally with sterile glucose at 10ul/g BW (20% D-glucose in 0.9% 
sterile saline; a solution that was prepared fresh on the day of use). Readings were taken at 
different time points (30, 60, 90 and 120 minutes) after injection. Groups on chow (C57B6 and 
TRIB3-/- mice) were treated the same. 
 
2.2.22 Insulin tolerance test (ITT) 
C57B6 and TRIB3-/- mice at week 11 were fasted for 2-3 hours on the morning of the 
experiment. They were weighed as insulin dose depends on its BW. Blood was then collected 
from tail to determine a baseline glucose reading, using glucose meter and strips, before 
injecting the mouse intraperitoneally with sterile insulin at 0.75 U/kg BW (0.25 U/ml in 0.9% 
sterile saline was freshly made up on the day, which was 3X BW in µl). Readings were taken at 
different time points (20, 40 and 60 minutes) after injection. Groups on chow (C57B6 and 
TRIB3-/- mice) were treated the same. In case the mice become hypoglycaemic, 20%             
D-glucose in 0.9% sterile saline was prepared to be quickly injected. 
 
2.2.23 Whole blood differential count (week 11) 
Blood was collected in the final week of the experiment (week 11) from C57B6 and TRIB3-/- 
mice through cardiac puncture using 1ml heparinised insulin syringes after anaesthetising mice 
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with isofluorane. A cell counting machine (Sysmex KX-21N; Sysmex Corporation) was used 
to calculate differential blood cell types for both groups. 
 
2.2.24 Blood plasma lipid profile 
Blood was centrifuged for 20 minutes at 250 x G, supernatant (plasma) then collected for lipid 
profile. Blood plasma lipid profiles (cholesterol, TG and HDL) of both C57B6 and TRIB3-/- 
mice were measured via enzymatic colorimetric test. Details and the process of measuring were 
previously described in 2.2.14. 
 
2.2.25 In vitro peritoneal cells 
Following the collection of blood and after cervical dislocation, 5ml of lavaging buffer was 
injected interperitoneal into C57B6 and TRIB3-/- mice. Peritoneal lavage fluid was recovered. 
The cells were cytospinned after counting. Differential cell types were counted from the 
cytospin of lavage microscopy slides. Neutrophil content in lavage then was calculated as per 
the formula described previously 2.2.13. 
 
2.2.26 Harvesting the organs 
Following the recovery of the peritoneal lavage fluid, organs were removed for further 
analysis, as required: adipose tissue, liver, heart and aorta:  
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2.2.26.1 Adipose tissue and liver 
A midline incision was made from the abdomen up to the chest using scissors. The long ribs 
and costodiaphragmatic recess was cut and removed. Adipose tissue was also removed and 
fixed in FBS (10% Formalin) at 4 °C. Adipose tissue was transferred to PBS after 24 hours in   
10% FBS. Liver was also excised and saved in liquid nitrogen.  
 
2.2.26.2 Heart and aorta 
1 ml PBS was injected directly into the heart, for flushing, followed by 1 ml FBS for fixation. 
Then aorta and heart were removed. Fat, vena cava, connective tissue and small branching 
vessels were detached from aorta. Once the aorta was cleaned it was opened exposing the 
internal surface. The heart was cut along the line of the atria. Next, all tissues were stored at     
4 °C until processing. They were transferred to PBS post 24 hours in 10% FBS. 
 
2.2.27 Preparing Oil Red O stain 
1 ml H2O was added to 99 ml isopropanol (propan-2-ol). Oil Red O powder was added to the 
solution until saturated, then filtered using Whatman filter paper. The final stain was diluted to 
60% v/v by H2O. 
 
2.2.28 En Face Oil Red O staining of aorta 
The aorta was stored in 10% FBS at 4 °C. The following day this was changed to PBS. The 
aorta was then stained using En Face Oil Red O staining as follow: aorta was rinsed in ddH2O 
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then in 60% isopropanol (2 minutes) followed by dipping in Oil Red O (10-15 minutes). Next, 
aorta was rinsed again in 60% isopropanol (2 minutes) then ddH2O before pinning out and 
photographing. 
 
2.2.29 Pinning out, capturing and analysis 
Melted wax was poured into a Petri dish. Once wax was firm, but warm, the aorta was placed 
on top and labelled (8 aortas per dish should fit). Insect pins were pinned through the aorta 
(pinning was done quickly as inserting pins are difficult when wax becomes cold). Aorta was 
dipped in PBS or H2O during pinning process and then the entire dish was covered with PBS to 
get clear picture. Photographs at 1.5x magnification were taken for image analysis. Percentage 
lesion coverage was measured, using NIS-Elements software. 
 
                                            object numbers  X  mean lesion area 
% Lesion coverage  =  _____________________________________          X  100   
                                                                total aorta area 
 
2.2.30 Dehydration and embedding heart, liver and adipose tissues 
Heart, liver or adipose tissue was placed into a plastic cassette with a sheet of Whatman Grade 
1 filter paper (heart did not require paper) after labelling samples with pencil. The cassettes 
were then covered with increasing concentrations of alcohol. 
 
	   60	  
  Dehydration sequence: 
50% Ethanol 1hour 
70% Ethanol 1hour 
90% Ethanol 1hour 
100% Ethanol 1hour 
100% Ethanol 1hour (Ethanol was changed) 
50:50 Ethanol/Xylene 1hour 
100% Xylene 1hour 
100% Xylene 1hour (Xylene was changed) 
The cassettes were immersed into pots containing melted wax in 60 °C oven over night. After 
dehydration the tissues were embedded into wax before sectioning them. 
 
2.2.31 Sectioning paraffin embedded murine heart, liver and 
adipose tissue 
Embedded heart, liver and adipose tissues from C57B6 and TRIB3-/- mice on 60% HFD and 
on chow (no heart samples on chow) were cut to sequential 5 µm thick sections (10 
slides/mouse) using a LEICA RM2135 Microtome. Sections were then floated out on a 37 ˚C 
water bath to smooth out wrinkles. Following this, each section was transferred to labelled 
microscopic slides before placing in a 37 ˚C incubator overnight to dry. 
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2.2.32 Re-hydrating in addition to staining heart, liver and adipose 
tissue slides 
For removing wax and re-hydrating tissues, heart, liver and adipose tissue slides were 
immersed in the following sequentially: 
• 100% Xylene                                         10 minutes 
• 100% Ethanol                                         2 minutes 
• 90% Ethanol                                           2 minutes 
• 70% Ethanol                                           2 minutes 
• Water                                                      2 minutes (to rinse alcohol off) 
Tissue slides were then stained with haematoxylin for 2 minutes to stain the nucleus of the 
cells. The slides were rinsed with distilled water (DW) to remove excess haematoxylin; stained 
with eosin for 30 seconds to stain eosinophilic structures of the cells and then rinsed with DW 
to remove excess eosin. A drop from DPX mounting medium was added to the slide’s centre to 
mount the glass coverslip gently on the slide. The slides were left overnight before visualising 
cells under the microscope. 
 
2.2.33 F4/80 immunohistochemistry for macrophages 
All test and control slides were de-waxed and re-hydrated via graded alcohols to water at room 
temperature (RT) as follows: 
100% Xylene               10 minutes 
100% Ethanol               2 minutes 
100% Ethanol               2 minutes 
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90% Ethanol                 2 minutes 
70% Ethanol                 2 minutes 
50% Ethanol                 2 minutes 
Water                            2 minutes 
Endogenous peroxidases were blocked by incubation in fresh 3% hydrogen peroxide (H2O2) 
(1:10 ratio of 30% stock solution and PBS) 10 minutes at RT. They were rinsed in tap water at 
RT. Antigen was retrieved by incubation in hot 10 mM sodium citrate buffer (pH 6) in a 95 ˚C 
water bath 20 minutes. Then container of citrate buffer with slides inside was removed, left to 
cool at RT 20 minutes and permeabilised by incubation in 0.5% Triton X-100 (1 ml Triton X-
100 in 200 ml PBS) at RT 10 minutes. Non-specific binding of secondary antibody was 
blocked with 1% milk buffer   (2 g milk in 200 ml PBS) at RT 30 minutes, following this, milk 
buffer was tipped off, but not washed, and the excess blotted. 100µl fresh primary antibody 
(1:100 ratio of anti-mouse F4/80 antigen and PBS) was added to each slide, covered with a 
plastic coverslip and incubated at 4 ˚C overnight before washing in 3 changes of PBS at RT     
5 minutes each. Then 100 µl fresh secondary antibody (1:200 ratio of biotinylated anti-rat IgG 
and PBS) was added to each slide, covered with a plastic coverslip and incubated at RT          
30 minutes before washing in 3 changes of PBS at RT 5 minutes each. Fresh Vectastain ABC-
HRP reagent (actin/biotin complex-HRP; 1 drop reagent A and 1 drop reagent B were added 
per 2.5 ml PBS, mixed and made up 30 minutes prior to use) was added to each slide, covered 
with a plastic coverslip, incubated at RT 30 minutes and washed in 3 changes of PBS 5 minutes 
each at RT. Following this, fresh DAB (1 drop buffer pH 7.5, 2 drops DAB and 1 drop H2O2 
were added per 2.5 ml ddH2O) was added to each slide, covered with a plastic coverslip, 
incubated at RT 10 minutes (in case colour development becomes too strong stop reaction 
early) and rinsed in tap water at RT. Slides were then counterstained using haematoxylin at RT 
1 minute, washed in water at RT, dehydrated via graded alcohols to xylene and mounted using 
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DPX mountant at RT. The primary and secondary antibodies, ABC and DAB incubations were 
carried out in a Humidifier. 
 
2.2.34 Statistical analysis 
Results are displayed as mean ± SEM. Statistical analysis was performed using GraphPad 
PRISM software version 5.00 (La Jolla, CA, USA). Statistical significance was tested using 
paired and unpaired student’s t tests (parametric tests) to compare two groups, whereas       
one-way ANOVA (analysis of variance), followed by Dunnett or Bonferroni post tests and 
two-way ANOVA were used for multiple comparisons. P values less than 0.05 were considered 
statistically significant. 
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Chapter 3: The role of p38 and Akt activation in murine 
neutrophil function in vitro 
 
3.1 Introduction 
p38 MAPK has a number of roles in inflammation, proliferation, differentiation, development, 
survival, apoptosis, in addition to stress responses [77]. Interestingly, published data indicated 
that PI3Kγ controls T cell activation, neutrophil migration, thymocyte development and the 
oxidative burst [61]. The interactions between TRIBs and other protein molecules have been 
the focus of many studies. Clearly, there are diverse experiments demonstrating an essential 
regulatory function for TRIBs in cellular regulation and development, although TRIBs’ role 
and molecular mechanism of action in signalling pathways are unclear as of yet [130]. All the 
above were discussed earlier in the thesis. 
As previously mentioned in the introduction, the control of MAPK cascades is essential for 
regulating various cellular responses. [145]. TRIBs bind to MAPKK and control the activation 
of MAPK. It has been documented that TRIBs may play an important role in the MAPK 
cascade, but at high concentrations they inhibit this cascade [145]. To explain these results, 
many mechanisms are hypothesised; for example, TRIBs could act as scaffolds [145]. TRIBs 
may behave either as activators of MAPK activity or as inhibitors, according to the TRIB to 
MAPKK ratio in the cell. Similarly, TRIB mediated regulation of NFκB [160], [161], and the 
control systems of the cell cycle have been found [162]. 
This chapter will build an understanding of TRIB3 action in the context of the effect of fMLP 
and KC on p38 MAPK and PI3K/Akt activation in murine neutrophils. It will discuss whether 
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knocking out TRIB3 alters specific signalling pathways, which in turn modulate murine 
neutrophil function, compared to C57B6 control. 
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3.2 RESULTS 	  
A) Evidencing existence of TRIB3 in neutrophils 
Unpublished data by my group have demonstrated that murine neutrophils express TRIB3 
(Table 1). This provides a rational for studying the function of TRIB3 in neutrophils. 
	  
 TRIB1 TRIB2 TRIB3 
Human 
neutrophils 
+ - + 
HL60 cells + - (+) 
Mouse 
neutrophils 
+ - + 
32Dcl3 cells + (+) + 
 
Table 3.1: Proving presence of TRIB3 in murine neutrophils 
It has been found by using conventional RT-PCR that TRIB3 mRNA is expressed in human and mouse 
neutrophils and cell lines. + High expression, (+) low level of expression and - no expression. 
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B) Effect of chemoattractants (KC and fMLP) and LPS on p38 and 
Akt activation in mouse neutrophils 
This section is to confirm what was shown in previous studies, regarding activation of p38 and 
Akt in murine neutrophils by KC, fMLP and LPS [175], [176]. The activation of isolated 
murine neutrophils through p38 or Akt was studied between 0-60 minutes, using diverse 
physiologically relevant stimuli (10-6 M KC, 10-6 M fMLP and 1ng/ml LPS). Activated cells 
were lysed and activation of p38 and Akt was detected by western blotting (Figure 3.1). The 
results show that exposure of isolated murine neutrophils to KC, fMLP and LPS activated the 
p38 MAPK signalling pathway at 15 and 30 minutes but this decreased at 60 minutes. It also 
shows insignificant inhibition on Akt signalling pathway by these stimuli. However, whilst 
there was an apparent trend to a transient activation of p38 and an inhibition trend on Akt in 
response to stimulation, statistical analysis (one-way ANOVA, Dunnett post test) did not show 
any significant difference. 
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Figure 3. 1:  Activation of p38 and Akt signalling by KC, fMLP and LPS in neutrophils 
Isolated murine neutrophils were stimulated for different periods of times (0, 15, 30 and 60 minutes) using various 
stimuli (10-6 M KC, 10-6 M fMLP or 1ng/ml LPS). The cells were then lysed with lysis buffer for 20 minutes on 
ice. Protein from neutrophil lysates was measured by the Bio-Red DC protein assay. Subsequently, protein was 
electrophoresed on a 30% SDS acrylamide gel, transferred to nitrocellulose membrane and identified with 
phospho p38 MAPK antibody and phospho Akt (ser 473) antibody, or p38 MAPK antibody and Akt antibody as 
primary antibodies. A secondary anti-rabbit IgG, HRP-conjugated antibody was added, and detected by enhanced 
chemiluminescence. Results are displayed as western blot images, using 0 minute as a control. KC and fMLP 
pictures are representative of 3 experiments, while 5 for LPS. 
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Figure 3. 2:  Quantification activation of p38 and Akt signalling by KC, fMLP and LPS in neutrophils 
Isolated murine neutrophils were stimulated for different periods of times (0, 15, 30 and 60 minutes) using various 
stimuli (10-6 M KC, 10-6 M fMLP or 1ng/ml LPS). Results are displayed as a ratio of the phospho p38 MAPK/p38 
MAPK (A) and phospho Akt/Akt (B) by densitometry. Data shows mean ± SEM, n = 4 for KC and fMLP and      
n = 5 for LPS. Statistical analysis (one-way ANOVA, Dunnett post test) was carried out using 0 minute as a 
control. No significant differences are observed. 
 
B 
A 
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C) Effect of chemoattractants (KC and fMLP) on p38 activation in 
murine neutrophils of C57B6 versus TRIB3-/- 
It has been found that p38 is activated by KC and fMLP in neutrophils [177]. This study is to 
clarify the importance of TRIB3 on this signalling pathway. Activation of isolated murine 
neutrophils through p38 MAPK was studied between 0-60 minutes, using diverse 
physiologically relevant stimuli (10-6 M KC, 10-6 M fMLP). Activated cells were lysed and 
activation of p38 MAPK was detected by western blotting (Figure 3.3). The results display that 
exposure of isolated murine neutrophils to KC and fMLP activated p38 MAPK signalling 
pathway at 15 and 30 minutes time points, with the signal then decreasing by 60 minutes in 
C57B6 and TRIB3-/-. Thus, no difference was observed between both groups for either 
chemoattractants. 
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Figure 3. 3:  Activation of p38 MAPK signalling by KC and fMLP in murine neutrophils of C57B6 versus 
TRIB3-/- 
Isolated murine neutrophils were stimulated for different periods of times (0, 15, 30 and 60 minutes) using various 
stimuli (10-6 M KC or 10-6 M fMLP). The cells were then lysed with lysis buffer for 20 minutes on ice. 
Subsequently, protein from neutrophil lysates were electrophoresed on a 30% SDS acrylamide gel, transferred to 
nitrocellulose membrane and identified with phospho p38 MAPK antibody or p38 MAPK antibody as primary 
antibodies. A secondary anti-rabbit IgG, HRP-conjugated antibody was added, and detected by enhanced 
chemiluminescence. Results are displayed as western blot images. Each picture is representative of 3 experiments. 
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D) Effect of fMLP and LPS on p38 MAPK activation in RAW 264.7 
cells 
p38 inhibitor (SB 203580) has previously been used in neutrophil migration assay successfully 
[49], [178], [179]. In this study human neutrophils were used to validate the function of p38 
inhibitor to investigate later whether migration of murine neutrophils in response to fMLP and 
KC occurred through the p38 MAPK pathway or other signaling pathways. The cells were pre-
incubated with 10 µM of p38 inhibitor for 30 minutes at 37˚C. Following this the cells were 
stimulated using 10-7 M fMLP between 0-30 minutes and compared to control cells without the 
p38 inhibitor pre-incubation. Whole cell lysates were made and phosphorylation of p38 was 
detected by western blotting. The results demonstrate that the neutrophils were already 
activated at 0 minute which made it difficult to differentiate the effect of 10-7 M fMLP as a 
stimulator for different periods of times (0, 10, 20 and 30 minutes) thus verifying the impact of 
p38 inhibitor. Therefore, activation of p38 MAPK in RAW 264.7 cells was studied between   
0-30 minutes using physiologically relevant stimuli (10-6 M fMLP or 50 ng/ml LPS). Activated 
cells were lysed and phosphorylation of p38 was detected by western blotting (Figure 3.4). 
The results show fMLP and LPS individually activated p38 MAPK signalling pathway in 
RAW 264.7 cells at 10-6 M and 50 ng/ml respectively compared to the untreated control. The 
effect of fMLP was more transient in comparison to LPS (i.e. there was an increase in p38 
phosphorylation at 10 minutes). This was not sustained for a long period of time as shown by 
the gradual decrease in the signal at 20 and 30 minutes. By contrast, LPS activation was longer 
lasting with a gradual increase in the signal for phosphorylated p38 with a greater activation at 
20 and 30 minutes when compared to fMLP.	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Figure 3. 4:  Activation of p38 MAPK signalling by fMLP and LPS in RAW 264.7 cells 
p38 MAPK in RAW 264.7 cells were stimulated for different periods of times (0, 10, 20 and 30 minutes) using 
various stimuli (10-6 M fMLP or 50 ng/ml LPS). The cells were then lysed with lysis buffer for 20 minutes on ice. 
Subsequently, protein (p38 MAPK) from RAW 264.7 cells lysates was electrophoresed on a 30% SDS acrylamide 
gel, transferred to nitrocellulose membrane and identified with phospho p38 MAPK antibody or p38 MAPK 
antibody as primary antibodies. A secondary anti-rabbit IgG, HRP-conjugated antibody was added, and detected 
by enhanced chemiluminescence. Results are displayed as western blot images, using 0 minute as a control. n = 1. 
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E) Verifying the impact of p38 inhibitor on kinase activity in RAW 
264.7 cells 
As it was impossible to determine whether the p38 inhibitor was functioning in the human 
neutrophils, the inhibitor was next tested on RAW 264.7 cells in order to validate the activity 
of p38 inhibitor and eventually study its effect on murine neutrophil migration towards fMLP 
and KC. The impact of p38 inhibitor on p38 MAPK signalling activity in RAW 264.7 cells 
post incubation for different periods of times (0, 30 and 60 minutes) at 30˚C was studied and 
compared to the control, using physiologically relevant stimulus 50 ng/ml LPS for 10 minutes. 
Treated cells were lysed and phosphorylation of p38 was detected through phospho ATF-2 by 
western blotting (Figure 3.5). 
The results show LPS activated at 10 minutes p38 MAPK signalling pathway, detected through 
phosphorylation ATF-2, in RAW 264.7 cells compared to the untreated control. The effect of 
phospho p38 on phosphorylation ATF-2 was longer lasting with a gradual increase in the signal 
for phosphorylated ATF-2 with a much greater activation at 30 and 60 minutes when compared 
to control. By contrast, adding 10 µM p38 inhibitor suppressed ATF-2 phosphorylation shown 
by the marked reduction in the signal in control cells and after LPS at 30 and 60 minutes. 
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Figure 3. 5:  Verifying the impact of p38 inhibitor on p38 MAPK activity in RAW 264.7 cells 
p38 MAPK in RAW 264.7 cells was stimulated for 10 minutes using 50 ng/ml LPS. The cells were then lysed 
with lysis buffer for 20 minutes on ice. Phospho p38 MAPK from RAW 264.7 cells lysates was immobilised by 
adding mAb bead slurry and incubated overnight at 4˚C. Cell lysates-immobilised Ab was centrifuged. The pellets 
were then suspended in kinase buffer, ATP and ATF-2 fusion protein (kinase substrate) before 10µM p38 inhibitor 
or vehicle control (DMSO) being added and incubated for different periods of times (0, 30 and 60 minutes) at 
30°C. Reaction was terminated by SDS sample buffer. Subsequently, phospho p38 MAPK was evaluated through 
detecting phospho ATF-2 by western blotting; protein samples (lysates) was electrophoresed on a 30% SDS 
acrylamide gel, transferred to nitrocellulose membrane and identified with primary antibody, phospho ATF-2 
antibody. A secondary anti-rabbit IgG, HRP-conjugated antibody was added, and detected by enhanced 
chemiluminescence. Unstimulated cells were used as a control. n = 1. 
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F) Verifying the impact of p38 inhibitor on kinase activity in murine 
neutrophils 
The impact of p38 inhibitor on p38 MAPK signalling activity in murine neutrophils after 
incubation for 60 minutes at 30˚C was tested and compared to the control to verify its effect 
and study it later on neutrophil migration towards KC and fMLP, using physiologically 
relevant stimulus 10-6 M fMLP for 30 minutes. Treated cells were lysed and phosphorylation of 
p38 was detected through phospho ATF-2 by western blotting (Figure 3.6). 
The results show fMLP activated at 30 minutes p38 MAPK signalling pathway, detected 
through phosphorylation ATF-2, in murine neutrophils at 10-6 M compared to the untreated 
control. The effect of phospho p38 on phosphorylation ATF-2 was greater, lasting 60 minutes 
when compared to control. By contrast, adding 10 µM p38 inhibitor inhibited ATF-2 
phosphorylation shown by a decrease in the signal at 60 minutes. This validated the function of 
p38 inhibitor. There is no similar commercially available kinase assay exists for PI3K inhibitor 
(LY 294002). Therefore, the activity of this inhibitor was not tested in my work. However, this 
molecule has previously been used in neutrophil migration assay [49]. 
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Figure 3. 6:  Verifying the impact of p38 inhibitor on p38 MAPK activity in murine neutrophils 
Murine neutrophils wild-type isolated from C57B6 were stimulated for 30 minutes using 10-6 M fMLP. The cells 
were then lysed with lysis buffer for 20 minutes on ice. Phospho p38 MAPK from lysates was immobilised by 
adding mAb bead slurry and incubated overnight at 4 °C. Cell lysates-immobilised Ab was centrifuged. The  
pellets were then suspended in kinase buffer, ATP and ATF-2 fusion protein (kinase substrate) before 10µM p38 
inhibitor or vehicle control (DMSO) being added and incubated for 60 minutes at 30°C. Reaction was terminated 
by SDS sample buffer. Subsequently, phospho p38 MAPK was evaluated through detecting phospho ATF-2 by 
western blotting; protein samples (lysates) was electrophoresed on a 30% SDS acrylamide gel, transferred to 
nitrocellulose membrane and identified with primary antibody, phospho ATF-2 antibody. A secondary anti-rabbit 
IgG, HRP-conjugated antibody was added, and detected by enhanced chemiluminescence. Unstimulated cells 
were used as a control. n = 1. 
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G) Effect of p38 MAPK and PI3K inhibitors on wild-type murine 
neutrophil migration in response to KC and fMLP 
Many studies showed opposing effects of p38 MAPK and PI3K inhibitors on mouse neutrophil 
chemotaxis towards KC and fMLP [49], [180], [179]. Therefore, this section will try to 
reconcile these results and firmly establish the impact of these inhibitors on chemotactic 
migration of purified murine neutrophils. Migration of murine neutrophils with and without 10 
µM of each p38 and PI3K inhibitors towards 10-5 M fMLP and 10-7 M KC were investigated 
by pre-incubating these cells with either p38 or PI3K inhibitors or their relevant vehicle control 
for 30 minutes at   37 °C. They were then incubated for 1 hour at 37 °C on filter membrane and 
the chemoattractant in the lower chamber of chemotaxis plate (Figures 3.7 and 3.8). 
Figures 3.7B and 3.8A show p38 and PI3K inhibitors significantly increased murine neutrophil 
chemotaxis towards 10-7 M KC and 10-5 M fMLP respectively compared to their controls 
(neutrophils without p38 or PI3K inhibitors). The p38 inhibitor decreased murine neutrophil 
migration towards fMLP at 10-5 M, whereas PI3K inhibitor increased cell migration to KC at 
10-7 M compared to their controls, although the results for both were not statistically significant 
(Figures 3.7A and 3.8B). 
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Figure 3. 7:  Verifying the impact of p38 inhibitor on migration of murine neutrophils towards fMLP and 
KC 
Neutrophils of wild type mice were re-suspended in a buffer (RPMI supplemented with BSA), and pre-incubated 
with p38 inhibitor (SB 239063) or vehicle control for 30 minutes at 37 °C. They were then incubated for 1 hour at 
37 °C, 5% CO2. The number of migrated neutrophils with and without 10 µM of p38 inhibitor responding to                 
10-5 M fMLP or 10-7 M KC was counted. Findings were corrected for chemokinesis (random migration) of 
neutrophils by subtracting the chemokinesis control. Data shows mean ± SEM, n = 3-5. Statistical analysis  
(paired t test) was carried out using neutrophils without inhibitor as a control. (* p < 0.05). The figure displays the 
migration as a percentage of the total number of neutrophils added to the filter (6 x 104). 
A 
 
 
 
 
 
 
 
 
B 
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Figure 3. 8:  Verifying the impact of PI3K inhibitor on migration of murine neutrophils towards fMLP and 
KC 
Neutrophils of wild type mice were re-suspended in a buffer (RPMI supplemented with BSA), and pre-incubated 
with PI3K inhibitor (LY 294002) or vehicle control for 30 minutes at 37 °C. They were then incubated for 1 hour 
at 37 °C, 5% CO2. The number of migrated neutrophils with and without 10 µM of PI3K inhibitor responding to    
10-5 M fMLP or 10-7 M KC was counted. Findings were corrected for chemokinesis (random migration) of 
neutrophils by subtracting the chemokinesis control. Data shows mean ± SEM, n = 3. Statistical analysis      
(paired t test) was carried out using neutrophils without inhibitor as a control. (* p < 0.05). The figure displays the 
migration as a percentage of the total number of neutrophils added to the filter (6 x 104). 
A 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
	   81	  
3.3 Discussion 
Neutrophils play an essential role in the inflammatory response. They represent the first line of 
defence against infection. Neutrophils respond to infection and/or tissue damage following 
chemoattractants (endogenous and bacterial signals) out of the blood vessels, via the 
interstitium to the place of infection [49]. Studies have confirmed that exposure of human 
neutrophils to fMLP [177] and LPS [181] activates p38 MAPK. The results of this experiment 
suggest that p38 MAPK signalling in neutrophils isolated from mice is stimulated by KC, 
fMLP and LPS for 15–30 minutes as seen in the western blot images (Figure 3.1). Although on 
initial inspection, the lack of statistical significance is evident; it is actually due to the different 
development timings of western blot processing that led to the varied results seen on 
densitometry (Figure 3.2A).  At later time points, a reduction in the stimulation was recorded; 
this may be due to phosphatase action which dephopshorylates active p38. In contrast, the data 
in figures 3.1 and 3.2B show that KC, fMLP and LPS had no significant inhibitory effect on 
Akt signalling in neutrophils. 
It has been published by Nick et al in 2000 that there is greater dependence on p38 pathway in 
the neutrophil compared to other WBC [182].  Separate data by Zu et al show in human 
neutrophils, activation of p38 MAPK is essential for the TNF-α- or fMLP-mediated cellular 
functions. This study proposed p38 MAPK may have a different function in response to 
distinct stimulation [177]. 
A further investigation on p38 phosphorlation has been conducted however, this time on two 
different groups (C57B6 and TRIB3-/- mice). Again neutrophils isolated from mice are 
stimulated by KC and fMLP for 15–30 minutes, through phosphorlation p38 MAPK, as 
illustrated in the western blot images (Figure 3.3), and then at a later time point (60 minutes) 
decreased. Surprisingly, this result shows no difference between C57B6, as a control, and 
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TRIB3 -/- mice. Therefore, our observations strongly suggest that TRIB3 does not control 
activation of neutrophils via p38 MAPK, as its deficiency does not alter p38 phosphorlation 
compared to C57B6, or it may be that its effect is minute to the extent it is undetectable by 
western blotting technique. 
Based on published observations in human neutrophils, neutrophils migrate towards the end 
target (fMLP) through activating p38 MAPK while they migrate towards intermediary 
chemoattractants such as IL-8 via PI3K/Akt [49]. Although the molecular mechanisms of 
neutrophil navigation remain unclear, it is known that leukocytes migrate in a step-by-step 
pathway via multiple different chemoattractants, responding to one agonist source after another 
[53]. A study by Heit et al suggested that PI3K is dispensable for neutrophil migration towards 
fMLP, though PI3K may enhance early responses to the fMLP. In contrast, p38 MAPK-
inhibited cells could not polarize in response to fMLP [180].  
Activation of murine neutrophils with chemoattractants such as fMLP and KC leads to various 
functional responses for example neutrophil migration, which we are interested in. This study 
assessed whether fMLP or KC stimulates murine neutrophil chemotaxis through p38 MAPK or 
PI3K in C57B6. Therefore, in the current study the impact of p38 inhibitor on kinase activity in 
RAW 264.7 cells was verified to assess the function of p38 inhibitor. This was successful 
(Figure 3.5), post testing the effect of fMLP and LPS on p38 MAPK activation in RAW 264.7 
cells and the results show fMLP and LPS individually activated p38 MAPK signalling pathway 
in RAW 264.7 cells compared to the untreated control (Figure 3.4). Finally, the impact of p38 
inhibitor on kinase activity in murine neutrophils was confirmed (Figure 3.6). Hence, the effect 
of p38 inhibitor on wild-type murine neutrophil migration in response to KC and fMLP was 
studied. 
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A study by Nick et al in 1997 demonstrated that fMLP activated MKK3 (the activator of p38 
MAPK). The p38 inhibitor decreased human neutrophil adhesion and chemotaxis in response 
to fMLP [59]. Cara et al in 2001 proposed that p38 has no effect on rolling or adhesion; 
however it is involved in neutrophil migration via tissue in response to KC in vivo. This study 
suggested KC stimulates p38 MAPK, which in turn phosphorylates downstream proteins such 
as LSP-1, to allow neutrophil chemotaxis [60]. A study by Knall et al demonstrated that 
neutrophil migration to IL8 is PI3K-dependent [183], [184]. In vivo PI3Kγ and PI3Kδ appear 
to have an indispensable function for the early and later phases of leukocyte recruitment 
respectively, in response to macrophage inflammatory proteins 2 (MIP-2) and KC significantly 
[185]. Research by Heit et al in 2008 showed PI3Kγ had a similar function in mediating 
neutrophil recruitment in response to fMLP [180]. 
The mechanisms that regulate neutrophil migration through various signalling pathways     
(p38 MAPK and PI3K) in response to different chemoattractants, fMLP or KC, is illustrated in 
figures 3.7 and 3.8. These show p38 inhibitor significantly increased murine neutrophil 
chemotaxis towards 10-7 M KC compared to its control, neutrophils without p38 MAPK 
inhibitor, (Figure 3.7B), whereas p38 MAPK inhibitor appeared to reduce murine neutrophil 
migration towards fMLP at 10-5 M, although the result was not statistically significant (Figure 
3.7A). On the other hand, PI3K inhibitor significantly increased murine neutrophil chemotaxis 
towards 10-5 M fMLP compared to its control, neutrophils without PI3K inhibitor (Figure 
3.8A). PI3K inhibitor also increased cell migration to KC at 10-7 M compared to its control, but 
again the result was not statistically significant (Figure 3.8B). This data clearly indicates that 
different signalling pathways for various stimuli control neutrophil migration, i.e. selective 
stimulation of signalling pathways may cause various neutrophil responses. An example of that 
is the varying effects of fMLP and KC stimuli on migration of neutrophils through p38 or PI3K 
pathways as demonstrated above. 
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In summary, my results suggest that TRIB3 may not control activation of neutrophils through 
p38 MAPK. Furthermore, evident data propose that neutrophil migration towards some 
chemoattractants, KC and fMLP, is dependent upon on various signalling pathways such as 
p38 MAPK and PI3K, which could be regulated by TRIB3 (see chapter 4). Given that there are 
discrepancies in the literature, in addition to observations in this project, further in vitro studies 
on the impact of TRIB3 on neutrophil function through various intracellular signalling 
pathways in response to various chemoattractants would be recommended. 
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Chapter 4: The role of TRIB3 in neutrophil function in 
vitro 
 
4.1 Introduction 
Neutrophil function relies on expression of adhesion molecules. They enable neutrophils to 
interact with endothelium. For example tethering and rolling of neutrophil on endothelial cells 
occurs via L-selectin, while firm adhesion and arresting happens through CD11b [186]. In 1995 
Phillips et al found that L-selectin is indispensable for circulating neutrophils [187]. In 
response to inflammation, stimulated neutrophils adhere to endothelium and aggregate with 
one another. Research by Guyer et al (1996) proposed that L-selectin and PSGL-1 support a 
collisional cell-cell interaction, which represents the initial stage of neutrophil aggregation 
[188]. 
It has been published by Cavanagh in 1998, increasing expression CD11b is a neutrophil 
activation marker. This adhesion complex permits neutrophil migration from the blood stream 
to the target [189]. Chen et al (2003) suggested neutrophil CD11b expression and reactive 
oxygen species (ROS) production could help to predict the stage of murine AIDS [190].  
Neutrophils migrate to sites of inflammation by a process known as chemotaxis [191]. 
Neutrophils are exposed to many different chemoattractants and evidence indicates a 
hierarchical status of these. End target chemoattractants (from infected sites) are prioritised by 
activating the p38 MAPK pathway. In comparison, the intermediate chemoattractants (which 
occur along the path) even at high level activate the PI3K/Akt cascade [49], [51], [52], [53], 
[54].  
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The PI3K cascade is one of the most important signalling pathways of neutrophil chemotaxis 
[58]. On the other hand, in humans and mice the p38 MAPK has an essential function in 
neutrophil chemotaxis [59], [60]. However, various aspects related to these pathways are still 
vague, such as the p38 MAPK and PI3K/Akt cascades are overlapping, opposing or 
complementary to each other [49].  
This chapter will verify whether TRIB3 controls the expression of adhesion molecules   
(PSGL-1, L-selectin and CD11b) on murine neutrophils with and without PMA stimulation by 
FACSCalibur flow cytometry. It will also discuss the impact of TRIB3 on neutrophil migration 
in response to KC and fMLP.  
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4.2 Results 	  
A) Effect of TRIB3 on PSGL-1, L-selectin and CD11b expression on 
PMA stimulated and un-stimulated murine neutrophils  
Expression of adhesion molecules (PSGL-1, L-selectin and CD11b) on murine neutrophils by 
various stimuli including PMA was already demonstrated in various studies, giving diverse 
findings [192], [193], [194]. This section will see the effect of PMA on expression of above 
adhesion molecules on neutrophils, in addition to testing the impact of TRIB3 on them. 
Expression of PSGL-1, L-selectin and CD11b on C57B6 and TRIB3-/- murine neutrophils was 
investigated by pre-incubating murine whole blood with or without 10-7 M PMA at 37 °C 
before adding the fluorescently conjugated antibodies. Absence of TRIB3 from murine 
neutrophils had no significant effect on expression of the above studied adhesion molecules on 
the cells. Stimulating both C57B6 and TRIB3-/- murine neutrophils with PMA significantly up 
regulated CD11b (Figure 4.3), but neither stimulating C57B6 nor TRIB3-/- murine neutrophils 
showed significant differences on expression of PSGL-1 compared to the un-stimulated cells 
(Figure 4.1). However, stimulating TRIB3-/- murine neutrophils with 10-7 M PMA 
demonstrated statistically significant shedding of L-selectin. In contrast, no significant 
shedding of L-selectin was observed in the wild type cells after stimulation (Figure 4.2). 
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Figure 4. 1: FACS determines adhesion molecule, PSGL-1, expressed on C57B6 and TRIB3-/- PMA 
stimulated and un-stimulated murine neutrophils  
C57B6 and TRIB3-/- murine whole blood samples were pre-incubated with/without 10-7 M PMA for 15 minutes 
at 37 °C, 5% CO2. Samples were incubated with fluorescently conjugated antibody (PE anti-mouse PSGL-1) and 
FITC anti-mouse Ly-6G (for labeling neutrophils). They were then incubated for 30 minutes on ice. Further 
incubation with 1% erythrolyse for 10 minutes at RT occurred prior to washing. Surface expression was 
determined by FACS. Data showed mean ± SEM, n = 3-4. Statistical analysis (one-way ANOVA, Bonferroni) was 
carried out.  
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Figure 4. 2: FACS determines adhesion molecule, L-selectin, expressed on C57B6 and TRIB3-/- PMA 
stimulated and un-stimulated murine neutrophils 
C57B6 and TRIB3-/- murine whole blood samples were pre-incubated with/without 10-7 M PMA for 15 minutes 
at 37 °C, 5% CO2. Samples were incubated with fluorescently conjugated antibody (PE anti-mouse L-selectin) and 
FITC anti-mouse Ly-6G (for labeling neutrophils). They were then incubated for 30 minutes on ice. Further 
incubation with 1% erythrolyse for 10 minutes at RT occurred prior to washing. Surface expression was 
determined by FACS. Data showed mean ± SEM, n = 6-8. Statistical analysis (one-way ANOVA, Bonferroni) was 
carried out. (** p < 0.01). 
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Figure 4. 3: FACS determines adhesion molecule, CD11b, expressed on C57B6 and TRIB3-/- PMA 
stimulated and un-stimulated murine neutrophils  
C57B6 and TRIB3-/- murine whole blood samples were pre-incubated with/without 10-7 M PMA for 15 minutes 
at 37 °C, 5% CO2. Samples were incubated with fluorescently conjugated antibody (PE Rat anti-mouse CD11b 
and FITC anti-mouse Ly-6G (for labeling neutrophils). They were then incubated for 30 minutes on ice. Further 
incubation with 1% erythrolyse for 10 minutes at RT occurred prior to washing. Surface expression was 
determined by FACS. Data showed mean ± SEM, n = 4-5. Statistical analysis (one-way ANOVA, Bonferroni) was 
carried out. (**** p < 0.0001). 
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B) Optimisation of chemoattractant concentrations on neutrophil 
migration  
KC, fMLP and LPS optimal concentrations on neutrophil migration were optimised in previous 
studies [195]. This section is to confirm these data and in the next section to apply it on TRIB3-
/- and study the impact of TRIB3 on neutrophil migration in response to different 
chemoattractants. Migration of isolated murine neutrophils to various stimuli (KC, fMLP and 
LPS) was demonstrated by incubating these cells for 3 hours at 37 ˚C on filter membrane and 
the chemoattractant in the lower chamber of chemotaxis plate (Boyden chamber). In addition, 
increasing concentrations of these chemoattractants was used to check their optimal 
concentration for neutrophil migration. The following figures show the migration of murine 
neutrophils towards KC, fMLP and LPS. 
KC significantly enhanced murine neutrophil chemotaxis compared to the control (buffer) at 
10-5–10-7 M (Figure 4.4). The maximum response was at 10-7 M. It can be seen from the figure 
that a lower concentration (10-8 M) reduced the functional response to the chemotactic factor in 
a dose-dependent manner, whilst at this level it still remained above the control level. On the 
other hand, fMLP enhanced murine neutrophil chemotaxis compared to the control at 10-5 M 
and 10-6 M (Figure 4.5). There was a significant increase in migration at 10-5 M, whilst there 
was a trend to an increased response at 10-6 M. It can be seen from the figure that the lower 
concentrations (10-6–10-8 M) reduced the functional response to the chemotactic factor. In 
contrast, LPS had no significant effect on murine neutrophil chemotaxis compared to the 
control at any of the concentrations used (Figure 4.6). Moreover, it can be seen from the graph 
that there were no trends observed. 
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Figure 4. 4: Migration of murine neutrophils towards KC 
Murine neutrophils isolated from C57B6 were re-suspended in buffer (RPMI supplemented with BSA) and 
incubated for 3 hours at 37 ˚C, 5% CO2 on filter membrane and the buffer or KC (10-5–10-8 M) in the lower 
chamber of chemotaxis plate. The number of migrated neutrophils responding to the buffer or KC was counted. 
Findings were corrected for chemokinesis (random migration) of neutrophils by subtracting the chemokinesis 
control from every value including the cells migrated to the buffer. Data shows mean ± SEM, n = 4. Statistical 
analysis (one-way ANOVA, Dunnett post test) was carried out using buffer as a control. (** p < 0.01 and          
*** p < 0.001). Figure displays the migration as a percentage of the total number of neutrophils added to the filter   
(6 x 104). 
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Figure 4. 5: Migration of murine neutrophils towards fMLP 
Murine neutrophils isolated from C57B6 were re-suspended in a buffer (RPMI supplemented with BSA) and 
incubated for 3 hours at 37 ˚C, 5% CO2 on filter membrane and the buffer or fMLP (10-5–10-8 M) in the lower 
chamber of chemotaxis plate. The number of migrated neutrophils responding to the buffer or fMLP was counted. 
Findings were corrected for chemokinesis (random migration) of neutrophils by subtracting the chemokinesis 
control from every value including the cells migrated to the buffer. Data shows mean ± SEM, n = 4. Statistical 
analysis (one-way ANOVA, Dunnett post- test) was carried out using buffer as a control. (*** p < 0.001). Figure 
displays the migration as a percentage of the total number of neutrophils added to the filter (6 x 104). 
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Figure 4. 6: Migration of murine neutrophils towards LPS 
Murine neutrophils isolated from C57B6 were re-suspended in a buffer (RPMI supplemented with BSA) and 
incubated for 3 hours at 37 ˚C, 5% CO2 on filter membrane and the buffer or LPS (10-8–100 ng/ml) in the lower 
chamber of chemotaxis plate. The number of migrated neutrophils responding to the buffer or LPS was counted. 
Findings were corrected for chemokinesis (random migration) of neutrophils by subtracting the chemokinesis 
control from every value including the cells migrated to the buffer. Data shows mean ± SEM, n = 5. Statistical 
analysis (one-way ANOVA, Dunnett post-test) was carried out using buffer as a control. There were no significant 
differences. Figure displays the migration as a percentage of the total number of neutrophils added to the filter     
(6 x 104). 
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C) Effect of TRIB3 on murine neutrophil chemotaxis in response to 
KC and fMLP 
Neutrophil migration towards KC and fMLP was already detected in different studies [49], 
[179]. However, the effect of TRIB3 on regulating that migration needs to be investigated. 
Therefore, the role of TRIB3 on murine neutrophil migration in response to KC and fMLP was 
studied by incubating C57B6 and TRIB3-/- neutrophil groups for 1 hour at 37 ˚C on filter 
membrane and the chemoattractant in the lower chamber of chemotaxis plate at increasing 
concentrations. The figures 4.7 and 4.8 below show the migration of murine neutrophils 
towards KC and fMLP. 
It can be seen from the graphs that absence of TRIB3 had no significant effect on neutrophil 
migration whether cells enhanced by KC or fMLP.  
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Figure 4. 7: Role of TRIB3 on murine neutrophil migration in response to KC 
Neutrophils isolated from C57B6 and TRIB3-/- mice were re-suspended in buffer (RPMI supplemented with 
BSA) and incubated for 1 hour at 37 ˚C, 5% CO2 on filter membrane and the buffer or KC (10-8–10-5 M) in the 
lower chamber of chemotaxis plate. The number of migrated neutrophils responding to the buffer or KC was 
counted. Findings were corrected for chemokinesis (random migration) of neutrophils by subtracting the 
chemokinesis control from each value including the cells migrated to the buffer. Data shows mean ± SEM, n = 4. 
Statistical analysis (one-way ANOVA, Bonferroni post-test) was carried out. There was no significant difference. 
Figure displays the migration as a percentage of the total number of neutrophils added to the filter (6 x 104). 
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Figure 4. 8: Role of TRIB3 on murine neutrophil migration in response to fMLP 
 Neutrophils isolated from C57B6 and TRIB3-/- mice were re-suspended in buffer (RPMI supplemented with 
BSA) and incubated for 1 hour at 37 ˚C, 5% CO2 on filter membrane and the buffer or fMLP (10-8–10-5 M) in the 
lower chamber of chemotaxis plate. The number of migrated neutrophils responding to the buffer or fMLP was 
counted. Findings were corrected for chemokinesis (random migration) of neutrophils by subtracting the 
chemokinesis control from each value including the cells migrated to the buffer. Data shows mean ± SEM, n = 4. 
Statistical analysis (one-way ANOVA, Bonferroni post-test) was carried out. There was no significant difference. 
Figure displays the migration as a percentage of the total number of neutrophils added to the filter (6 x 104). 
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4.3 Discussion 
Neutrophil migration is essential to physiological and pathological processes. Preceding 
investigations have recorded a relationship between fMLP [49], [180], [53] and IL-8, an 
intermediary chemoattractant that is equivalent to KC in mice and migration of neutrophils 
[49], [53]. It has been observed that chemokines in a concentration gradient can bind with 
leukocytes through GPCRs which result in leukocyte directional migration [53]. Furthermore, 
each class of leukocyte is able to respond to a variety of chemokines [53], and since this study 
is about neutrophils, attention has been focused on this class. 
Given the above, positive results were recorded in these experiments, the murine neutrophils 
migrated to KC and fMLP (intermediary and end target [49] chemoattractants respectively) as 
displayed in figures 4.4 and 4.5. However, there was no migration to LPS (Figure 4.6), 
although p38 MAPK signalling in neutrophils is stimulated by LPS, suggesting LPS is capable 
of activating neutrophils but does not act as a chemoattractant. Furthermore, a study by 
Aomatsu et al found that human neutrophils displayed increased random motility but not 
directed migration after stimulation with LPS within 10 minutes which lasted for more than 90 
minutes, leading to activation of ERK and p38 MAPK [181]. This observation is also seen in 
the data shown in figure 4.6. 
In this project, I have investigated the response of freshly isolated neutrophils to intermediate 
(KC) and end target (fMLP) chemokines from wild type mouse and found that the optimal 
concentration for KC was 10-7 M whereas, 10-5 M for fMLP. 
It also assesses whether knockout TRIB3 affects neutrophil chemotaxis differently. The results 
(Figures 4.7 and 4.8) clearly highlight no profound differences between TRIB3-/- mice and the 
control in neutrophil migration towards KC or fMLP. The concentrations of KC used were 
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similar to that used for the control. In the controls this proved optimal in maximizing 
neutrophil migration. There were hardly any differences between C57B6 and TRIB3-/- mice. 
These findings may indicate that TRIB3 has no effect on neutrophil migration towards KC. The 
other explanation for this could be that optimum KC concentration for the wild type is too high 
for TRIB3-/- mice, which may have resulted in excess KC binding with other receptors. This in 
turn inhibits neutrophil migration. Hence, if lower concentrations were used, differences may 
have been observed. However, a limitation on the number of mice available prevented further 
experiments. 
Interestingly, there was a trend to an increased response to KC at 10-5 M in TRIB3-/- mice 
compared to C57B6. There was also a trend to an increased response to fMLP at 10-7 M and  
10-6 M. This possibly increased the sensitivity of neutrophil migration towards chemoattractant 
due to the knockout of TRIB3. This was confirmed by the data in chapter 5 whilst studying the 
effect of TRIB3 on neutrophil recruitment in thioglycollate-induced peritonitis. The neutrophil 
influx of TRIB3-/- mice towards the peritoneum was greater than the neurophil influx of 
C57B6 at 2 hours, but it was not found to be significant. Therefore, TRIB3 may control 
neutrophil chemotaxis in response to different chemoattractants (KC and fMLP). However, to 
find a significant effect the number of experiments conducted should be increased. 
A study by Davenpeck et al (2000) verified that exposure of neutrophils to PAF or PMA 
results in activated cells, which in turn reduced surface expression of PSGL-1 within minutes 
[192]. Neeley et al published with his group the expression of L-selectin on purified human 
neutrophils caused by varied activators. The results show PAF and fMLP reduced L-selectin 
expression in neutrophils, but IL-5 had no effect on the expression of L-selectin in the cells 
[193]. Siddiqi et al in 2001 found CD11b expression is clearly increased in PMA-stimulated 
neutrophils [194].  
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Figures 4.1–4.3 compared murine neutrophils from both wild type and TRIB3-/- mice. This 
illustrated that no significant difference was seen in the expression of adhesion molecules 
(PSGL-1, L-selectin and CD11b) on neutrophils for both types, whether the cells were 
stimulated with 10-7 M PMA or not. This excludes the effect of TRIB3 on the expression of 
these adhesion molecules on murine neutrophils, although there was a trend towards higher    
L-selectin expression in TRIB3-/- mice before stimulation. However, stimulation of neutrophils 
with PMA showed significant differences in the expression of adhesion molecules in both 
groups (C57B6 and TRIB3-/- mice). Some shedding of L-selectin in PMA post-stimulated 
C57B6 neutrophils was noted but this was not as significant as quoted in other studies in the 
literature. In contrast, TRIB3-/- post-stimulated neutrophils demonstrated shedding of             
L-selectin, giving statistically significant result (Figure 4.2). On the other hand, stimulating 
both C57B6 and TRIB3-/- murine neutrophils with PMA significantly up regulated CD11b 
(Figure 4.3), but neither stimulating C57B6 nor TRIB3-/- neutrophils showed significant 
differences on expression of PSGL-1 compared to the un-stimulated cells (Figure 4.1). Thus, 
this result would suggest that removing TRIB3 and stimulating the neutraphils has a significant 
effect on the shedding of L-selectin from the cell surface. It is thought that the key in 
increasing CD11b expression is the stimulation of the cells not TRIB3 effect, as in both PMA 
post-stimulated neutrophil groups CD11b was up regulated significantly, while with PSGL-1 
neither removing TRIB3 nor stimulation the cells has an impact on PSGL-1 expression. The 
discrepancies in the literature and the in vitro observations of this project may be a 
consequence of certain variables such as the possibility of infection in mice and technical 
differences (selection of samples, substances, concentration and the process of eliminating the 
erythrocytes). 
In summary, this study clearly excludes the significant effect of TRIB3 on the expression of 
adhesion molecules on murine neutrophils. However, it does show stimulation of the cells with 
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PMA may regulate expression significantly, some up and others down-regulation in C57B6 and 
TRIB3-/- mice. Furthermore, clear data propose that neutrophil migration towards some 
chemoattractants, KC and fMLP, is dependent upon on various signalling pathways such as 
p38 MAPK and PI3K (seen in chapter 3), which could be regulated by TRIB3. Again, due to 
inconsistencies in research and observations in this study, additional in vitro studies on the 
impact of TRIB3 on neutrophil migration and adhesion molecules would be suggested. 
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Chapter 5: The role of TRIB3 on neutrophilic 
inflammation in vivo 
 
5.1 Introduction 
Cytokines act as chemical messengers binding to specific receptors, regulating the behaviour of 
other cells. They affect differentiation, development, growth, blood clotting and repair of the 
target cells. Furthermore, cytokines have an essential role in defending the immune system 
against disease. 
This chapter will review whether TRIB3 regulates cytokine levels in lavage fluid derived from 
mice with thioglycollate-induced peritonitis using BD CBA. We also studied whether 
neutrophil migration across the microvasculature and invasion are influenced by the TRIB3 
altered cytokine level. In addition, the effect of knocking out TRIB3 on WBC recruitment in 
blood and on the type of WBC recruited in murine peritoneal lavage fluid was investigated in 
both groups. These were collected at different time points after injecting 4% thioglycollate 
intraperitoneally.  
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5.2 Results 	  
A) Function of TRIB3 on murine cytokine levels in thioglycollate-
induced peritonitis 
Diverse studies have revealed that cytokines are required for neutrophil recruitment [196], 
[197]. However, the impact of TRIB3 on controlling their levels has not previously been 
investigated. Therefore, the effect of knocking out TRIB3 on different murine cytokine levels 
in thioglycollate-induced peritonitis of lavage fluid was demonstrated by injecting wild type 
and TRIB3-/- mice intraperitoneally with 4% thioglycollate prior to collecting peritoneal 
lavage fluid from each group at different time points. Levels of cytokines in lavage fluid were 
quantified using CBA. TRIB3 deficiency increased murine IL-13 level in thioglycollate-
induced peritonitis significantly compared to the control (Figure 5.1). Table 5.1 below 
illustrates the levels of each cytokine (GMCSF, IL-4, IL-13, IL-17A, KC, MCP-1, MIP-1α, 
MIP-1β and TNF) individually for lavage fluid.  
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 0 h 2 h 6 h 
 C57B6  TRIB3-/- C57B6  TRIB3-/- C57B6  TRIB3-/- 
GMCSF ND ND ND 42.99 ± 3.93 398.25 ± 21.80 347.67 ± 30.82 
IL4 ND ND ND ND 329.00 ± 8.44 363.67 ± 38.65 
IL13 ND ND ND ND 235.25 ± 8.23  273.67 ± 12.88** 
IL17A ND ND 24.73 ± 4.90 221.02 ± 43.20 6331.00 ± 1438.11 7730.33 ± 4129.74 
KC ND ND 28.26 ± 17.07 42.42 ± 12.36 59637.00 ± 1816.09 55618.33 ± 27426.97 
MCP-1 23.33 ± 3.80 22.57 ± 3.90 851.34 ± 116.44 2979.14 ± 904.74 78182.00 ± 1923.31 63830.67 ± 31022.49 
MIP-1 alpha ND ND 558.56 ± 99.72 833.22 ± 52.80 47103.75 ± 1522.35 40400.33 ± 20007.93 
MIP-1 beta ND ND 130.34 ± 42.04 225.79 ± 41.37 3382.25 ± 101.60 2799.67 ± 927.13 
TNF ND ND 451.26 ± 51.74 629.41 ± 37.74 3258.25 ± 425.52 2659.33 ± 1218.54 
 
 
 
Table 5.1: Effect of TRIB3 on murine cytokine levels in thioglycollate-induced peritonitis of lavage fluid 
The table shows levels of cytokines in thioglycollate-induced peritonitis of lavage fluid of wild type versus 
TRIB3-/- mice, using BD CBA. Cytokine levels were measured in lavage fluid, taken at different time points      
(0, 2, 6 and 24 hours) after injecting 4% thioglycollate intraperitoneally. Data show mean ± SEM in pg/ml. Each 
group is represented by 3-4 mice at each time point (n). Statistical significance was tested using one-way 
ANOVA, followed by Bonferroni post test (** p < 0.01). C57B6 served as a control. ND: below the detection 
limit of the kit  (<10 pg/ml). 
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Figure 5. 1: Effect of TRIB3 on murine IL-13 level in thioglycollate-induced peritonitis of lavage fluid 
The graph illustrates IL-13 concentrations in thioglycollate-induced peritonitis of lavage fluid of wild type versus 
TRIB3-/- mice, using BD CBA. IL-13 level was measured in lavage fluid, taken at different time points              
(0, 2, 6 and 24 hours) after injecting 4% thioglycollate intraperitoneally. Data show mean ± SEM in pg/ml. Each 
group is represented by 3-4 mice at each time point (n). Statistical significance was tested using one-way 
ANOVA, followed by Bonferroni post test (** p < 0.01). C57B6 served as a control. Values below the detection 
limit (10 pg/ml) of the kit are undetectable by this experiment. 
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B) Function of TRIB3 on WBC recruitment in thioglycollate-
induced peritonitis 
Leukocyte chemotaxis in response to various chemoattractants was studied extensively [198]. 
The current study will see the role of TRIB3 on their migration. The effect of absence of 
TRIB3 on murine leukocyte recruitment in thioglycollate-induced peritonitis were investigated 
by injecting C57B6 and TRIB3-/- mice intraperitoneally with 4% thioglycollate before 
collecting blood and peritoneal lavage fluid from each group at different time points. The level 
of circulating leukocytes was significantly less in TRIB3 deficient animals compared to the 
control (Figure 5.2). Figures 5.3A–C demonstrate the total leukocyte cell count versus 
neutrophils (including the percentage) between 2 to 48 hours in peritoneal lavage specimens. 
The graphs highlight that at 2 hours mononuclear cells predominated, but at 6 hours this was 
reversed, demonstrating a predominance of neutrophils in both groups. In addition, there was a 
trend towards an increased neutrophil migration in the peritoneum at 2 hours and persisted at 
24 hours in the TRIB3-/- mice compared to the control.  
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Figure 5. 2: Effect of TRIB3 on blood leukocyte recruitment in thioglycollate-induced peritonitis 
The number of migrated leukocytes in blood of thioglycollate-induced peritonitis in C57B6 versus TRIB3-/- mice 
were counted. Samples were collected at different time points (0, 2, 6 and 24 hours) after injecting                       
4% thioglycollate intraperitoneally. Data show mean ± SEM. Each group is represented by 3-6 mice at each time 
point. Statistical significance was tested using one-way ANOVA, followed by Bonferroni post test                       
(* p < 0.05, ** p < 0.01 and **** p < 0.0001). C57B6 served as a control.  
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Figure 5. 3: Effect of TRIB3 on peritoneal lavage fluid leukocyte recruitment in thioglycollate-induced 
peritonitis 
The number of migrated leukocytes in peritoneal lavage fluid of thioglycollate-induced peritonitis in C57B6 versus TRIB3-/- mice were 
counted (A). Samples were collected at different time points (0, 2, 6, 24 and 48 hours) after injecting 4% thioglycollate intraperitoneally. 
Following counting the cells in peritoneal lavage fluid, the cells were cytospined to obtain the percentage of neutrophils (B) and then the total 
number of neutrophils was calculated (C). D-H show pictures of neutrophils recruited in lavage fluid in thioglycollate-induced peritonitis of 
C57B6 after 0, 2, 6, 24 and 48 hours respectively, whereas I-M belong to TRIB3-/- mice. Data show mean ± SEM. Each group is represented 
by 3-6 mice at each time point. Statistical significance was tested using one-way ANOVA, followed by Bonferroni post test (* p < 0.05). 
C57B6 served as a control. Neutrophil (N). 
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5.3 Discussion 
It is well known that upon infection leukocytes would migrate to the site of infection as a 
protective attempt to eliminate the injurious stimuli. The previous view held that the greatest 
number of neutrophils from murine peritoneal cavities was harvested when mice were 
sacrificed 5 hours post intraperitoneal injection of thioglycolate medium [199]. 
We investigated the effect of thioglycollate-induced peritonitis at different time points post 
injecting thioglycollate intraperitoneally, and then studied whether knocking out TRIB3 
modulates leukocyte migration to the blood and peritoneum. Graphs 5.2 and 5.3 demonstrate 
leukocyte numbers in blood and that migrated to the peritoneum respectively in response to 
thioglycollate. Interestingly, Graph 5.2 demonstrates that blood leukocyte level in the TRIB3-/- 
mice is less than that of the control and this is noted to be significant at 2 and 6 hours. 
However, a marked fall in the leukocyte count is recorded in the control at 24 hours, probably 
resulting in they are went through apoptosis. It appears that knocking out TRIB3 prevents the 
increase in circulating leukocyte levels seen in the wild type after thioglycollate injection. With 
regards to leukocyte migration to peritoneum there is no recorded difference in either category 
(Figure 5.3A). Therefore, neutrophils that have migrated to the peritoneum were tested. As a 
result, it is very clear from figure 5.3C compared to figure 5.3A that the number of neutraphils 
at 6 hours, for both groups (C57B6 and TRIB3-/- mice), predominated. Figure 5.3C also 
illustrates knockout of TRIB3 may increase sensitivity of neutrophil migration. A trend of 
increase neutrophil migration of TRIB3-/- mice towards peritoneum at 2 hours compared to 
C57B6. This result was confirmed by the data in chapter 4 when studying the effect of TRIB3 
on murine neutrophil migration in response to KC and fMLP; as neutrophil influx of TRIB3-/- 
mice towards KC at 10-5 M and fMLP at 10-7 M and 10-6 M was greater than C57B6, but was 
not found to be significant. Figure 5.3C also shows neutrophil numbers in lavage fluid increase 
with time for both thioglycollate-induced peritonitis groups up to 6 and 24 hours respectively. 
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At later time points, a reduction in the neutrophil numbers was recorded, as they are thought to 
undergo apoptosis. It is clear that knocking out TRIB3 from murine cells had no significant 
effect on neutrophil migration. Furthermore, neutrophil migration in TRIB3-/- mice persisted 
and continued to increase at 24 hours compared to the control which decreased after 6 hours 
until a minimal number migrated at 24 hours (again there was no significance), which possibly 
due to TRIB3 deficiency leading to delay in neutrophil apoptosis. The percentage of migrated 
neutrophils in thioglycollate-induced peritonitis mice was measured and it showed no 
significant difference between both groups at any time point (Figure 5.3B). Taking into account 
the results of the effect of TRIB3-/- on murine multi-cytokine levels in thioglycollate-induced 
peritonitis of lavage fluid, it is clear that cytokine levels increase with time for both 
thioglycollate-induced peritonitis groups (Table 5.1 and Figure 5.1). This indicates that the 
initial process occurring after introducing thioglycollate is increasing levels of neutrophil-
attracting chemokines at the site of infection. This could explain the increase in recruiting 
neutrophils at the peritoneum as an inflammatory response by either a direct or indirect 
mechanism as a chemoattractant. Considerable volume of research has looked at direct 
mechanism as a chemoattractant. An article published in the Journal of Leukocyte Biology in 
2011 demonstrated that GMCSF is a chemoattractant for murine neutrophil as verified in vivo 
[196]. Further studies have revealed that IL-17A and IFN-γ are produced by neutrophils, which 
in turn may up-regulate neutrophil transmigration in mouse kidney ischemia-reperfusion injury 
[200]. 	  
An in vivo study in 2008 demonstrated that murine tissue macrophage TLR signaling directly 
induces neutrophil-attracting chemokines (KC and MIP-2) synthesis. These chemokines 
constitute the key for neutrophil migration, which represents the earliest immune cells to 
recruit into infected tissue [197]. Furthermore, a study published in 2004 concluded that 
neutrophils migrating into inflammatory tissues from intravascular space are induced by the 
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basement membrane to secrete the chemokine MIP-1 β, this in turn caused dendritic cells to 
migrate in the same way [201]. 
When looking at literature for indirect mechanisms Ratthé et al 2009 found that IL-4 
significantly increased the number of leukocytes (neutrophils and monocytes) in vivo murine 
air pouch model by an indirect mechanism. This mechanism involved the up regulation of the 
chemoattractant MCP-1 [202]. Further research has showed that IL-13 activates human 
neutrophils to modulate the synthesis of many neutrophil proteins (e.g. IL-8, IL-1R antagonist 
and IL-1 decoy receptor), which involve increases in tyrosine phosphorylation by tyrosine 
kinases [203]. A study in 2005 revealed that neutrophil accumulation occurred in an 
experimental model of allergen-induced immune inflammation in the murine peritoneum is 
mediated by macrophage-inflammatory protein (MIP)-1α that induces sequential release of 
TNF-α and LTB4 through C-C chemokine receptor type 1 (CCR1) [204]. 
In contrast with the increase in cytokine levels with time for both thioglycollate-induced 
peritonitis groups, knocking out TRIB3 from murine cells had an effect on several cytokines 
and it is time dependent, GMCSF, IL-17A and MCP-1 at 2 hours and IL-13 at 6 hours 
compared to the control, although the findings were not statistically significant except for     
IL-13 (Table 5.1 and Figure 5.1). As a result of this, it may be that TRIB3 down regulates these 
cytokines at a certain point in time, although this regulation has no considerable effect on 
neutrophil migration (Figures 4.7 and 4.8 illustrated in chapter 4). Nevertheless, there has been 
a general agreement on the chemoattractants involved in neutrophil recruitment, the 
mechanisms by which neutrophils recruit between endothelia and migrate into the 
inflammatory site remains unclear.  
Overall these observations suggest that some cytokines are involved in increasing neutrophil 
migration across the microvasculature and invasion of the affected tissue by different 
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mechanisms. In addition to this, TRIB3 controls cytokine levels. TRIB3 deficiency was also 
found to inhibit the increase in circulating leukocyte number significantly; may increase 
neutrophil migration towards peritoneum (inflammation site) and may extend their existence 
when compared to the control in thioglycollate-induced peritonitis, due to possible effect of 
TRIB3 deficiency on neutrophil appoptosis. The control was found to be transient as their 
neutrophils migrated and left the peritoneum rapidly. Interpretation of the in vivo cytokine and 
TRIB3 results is hindered by the fact that the mechanisms are still to be discovered, as 
cytokines are a prerequisite for neutrophil emigration with TRIB3 regulating several of these. 
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Chapter 6: The role of TRIB3 in insulin resistance, control 
of lipid homeostasis and in the development of 
atherosclerosis 
 
6.1 Introduction 
TRIBs coordinate the activation and suppression of various cascades. They have an essential 
function in determining cell fate during response to environmental challenges [131]. 
Specifically, TRIB3 has been published by most [153], [155] but not all [167] studies to 
dysregulate insulin action via interacting with Akt in murine models of diabetes. Increasing 
levels of TRIB3 may lead to insulin resistance in mice [153], [155]. Data by Weismann et al 
observed TRIB3 knockdown rats gained considerable weight, improved insulin sensitivity and 
increased expression of PPAR-γ. Interestingly, there was no remarkable variation in Akt 
activation, which suggest TRIB3 may regulate lipid synthesis through a PI3K-independent but 
PPAR-γ-mediated mechanism [170]. 
Publication by Koo et al suggested TRIB3 an important regulator of glucose and lipid 
metabolism, as its expression was induced by fasting through induction of PPARα [155]. 
Despite the discrepancies in the literature, it seems logical to propose that TRIB3 may be a 
critical modulator of signalling mechanisms regulating lipid homeostasis. Impairment in 
TRIB3 function may lead to the development of serious disease such as type 2 diabetes. Given 
the prevalence of cardiovascular disease, studying genes, for instance TRIB3, contributing to 
the impaired lipid homeostasis and insulin resistance was taken the priority of this study. 
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This chapter attempts to synthesise knowledge obtained on TRIB3 action in the context of lipid 
homeostasis, insulin resistance as well as discussing the importance of TRIB3 in developing 
atherosclerosis. It will study whether knocking out TRIB3 modulates growth rate of mice on 
chow and 60% HFD compared to C57B6 control mice and review its effect on the quantity and 
type of WBC in mouse blood and peritoneal lavage fluid of both groups. Furthermore, it will 
show the effect of TRIB3 on insulin resistance in glucose- or insulin-injected mice again on 
normal and HFD, taking the glucose readings at different time points, in addition to the 
baseline glucose reading before intraperitoneal injection. In addition to this we will look at the 
role of TRIB3 in lipid homeostasis and development of atherosclerosis. Aortas were stained by 
Oil Red O to distinguish the plaque regions post feeding the mice 60% HFD for 11 weeks. 
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6.2 Results 	  
A) Role of TRIB3 on weight gain of mice on 60% HFD and gender 
effect on TRIB3-/- mice weight fed chow 
Murine weight gain has been recorded formerly, but the impact of TRIB3 deficiency and 
feeding the mice HFD on it requires investigation. The role of TRIB3 on male murine weight 
gain was studied on C57B6 and TRIB3-/- groups fed 60% HFD for 11 weeks. Both groups 
were weighed every week and matched with their ages (Figure 6.1A). The percentage weight 
gain was then measured (Figure 6.1B). Data demonstrates that TRIB3 deficiency and HFD in 
combination alter murine weight gain. The data also shows that the effect of TRIB3 deficiency 
on weight was gender specific, as TRIB3-/- males weighed more than the C57B6 males 
significantly but not females (Figures 6.2A and 6.2B). 
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Figure 6. 1: Effect of TRIB3 on weight gain of male mice on 60% HFD 
(A) C57B6 versus TRIB3-/- mice were fed 60% HFD for 11 weeks. Weight was taken every week for both 
groups. They were males and aged 18 week upon commencement of fat feeding. The readings were taken for      
11 weeks, initiating with a baseline weight before fat feeding begins. (B) Represents the percentage of weight 
gain. Data show mean ± SEM. Every group is represented by 7 mice at each condition. Statistical significance was 
tested using two-way ANOVA. C57B6 served as a control (*** p < 0.001). 
A 
 
 
 
 
 
 
 
 
 
B 
	   118	  
	  
 
 
Figure 6. 2: Gender specific effect of TRIB3 on weight for chow fed mice 
18 week aged males (A) and 14 week aged females (B) C57B6 versus TRIB3-/- mice respectively were fed chow. 
Data show mean ± SEM. The male groups consist of 7 of each C57B6 and TRIB3-/- mice. The female groups 
consist of 5 C57B6 and 3 TRIB3 mice. Statistical significance was tested using unpaired t test. C57B6 served as a 
control (* p < 0.05). 
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B) Role of TRIB3 on WBC quantity in the peritoneal lavage fluid in 
mice fed 60% HFD 
Leukocyte numbers in peritoneum during an inflammatory response have previously been 
reported [205]. This study will highlight the possible influence of TRIB3 on peritoneal 
leukocyte quantity.	  The function of TRIB3 on WBC quantity in the peritoneal lavage fluid was 
investigated after feeding C57B6 and TRIB3-/- groups 60% HFD for 11 weeks. Knocking out 
TRIB3 significantly increased leukocyte numbers in peritoneum compared to C57B6 (Figure 
6.3A) but this was not observed specifically to neutrophils in either group (Figures 6.3B and C).	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Figure 6. 3: Effect of TRIB3 on WBC quantity in the peritoneal lavage fluid in mice fed 60% HFD 
The number of leukocytes from peritoneal lavage fluid of C57B6 versus TRIB3-/- mice was counted (A). Samples 
were collected after feeding mice for 11 weeks 60% HFD. Following counting the cells, a cytospin was performed 
on peritoneal lavage fluid of C57B6 (B) and TRIB3-/- (C) mice. Data show mean ± SEM. Each group is 
represented by 7 mice. Statistical significance was tested using unpaired t test (*** p < 0.001). C57B6 served as a 
control.	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C) Role of TRIB3 on WBC types in mouse blood fed chow and 60% 
HFD 
Circulating leukocyte subsets that are involved in inflammation have been studied widely [205]. 
Yet, the importance of TRIB3 on the quantity of these cells needs to be investigated. The role 
of TRIB3 on leukocyte types circulating in mouse blood was studied after feeding mice normal 
and 60% HFD for 5 and 11 weeks. Graph 6.4A illustrates no significant difference in the 
number of leukocytes in TRIB3-/- blood compared to the control regardless of whether the 
mice were on normal or HFD. However, post long period of time (11 weeks) feeding both 
groups 60% HFD resulted in significantly lower leukocyte numbers than feeding them for 5 
weeks. Considering the leukocyte types, lymphocytes were shown to predominate in both 
groups whether on chow or HFD, except C57B6 mice on a normal diet as the majority was 
shared between lymphocytes and neutrophils. Furthermore, knocking out TRIB3 down-
regulated only neutrophils significantly in mice fed normal food. On the other hand, feeding 
the mice 60% HFD reduced neutrophil and monocyte numbers significantly in both blood 
groups, while the significant reduction in lymphocytes was just restricted to C57B6 group on 
diet for 11 weeks compared to 5 weeks feeding of the same group (Graphs 6.4B–D). 
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Figure 6. 4: Role of TRIB3 on WBC types in mouse blood fed chow and 60% HFD 
The number of leukocyte in blood of C57B6 versus TRIB3-/- mice was counted (A). Samples were collected at 
different time points; 0, 5 and 11 weeks after feeding the two groups 60% HFD. B-D represent the number of 
lymphocytes, monocytes and neutrophils in blood/l respectively, while E-G are the percentage of these cells (same 
order). Data show mean ± SEM. Each group is represented by 4-7 mice at each time point. Statistical significance 
was tested using one-way ANOVA, followed by Bonferroni post test (* p < 0.05, ** p < 0.01 and *** p < 0.001). 
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D) Role of TRIB3 in insulin sensitivity in mouse blood fed chow and 
60% HFD 
Whilst there are wide range studies in terms of impact of TRIB3 on insulin sensitivity [170], its 
molecular mechanism remains incomplete and its physiological function controversial. This 
study will confirm/contradict what have already been published. The effect of TRIB3 
deficiency on glucose concentration at different time points was investigated in mice injected 
with glucose or insulin that were fed with normal and 60% HFD food. Figure 6.5 demonstrated 
that no matter if the mice in both groups were fed with chow or HFD, their glucose 
concentration have increased trend after 30 minutes from injecting of glucose. The trend of 
glucose level remained elevated significantly in TRIB3-/- mice on HFD, while it returned to 
the base line after 2 hours from injection in other groups (both C57B6 groups on chow and 
HFD, and TRIB3-/- group on chow). In contrast, figure 6.6 showed a significantly decreased 
blood glucose concentration in C57B6 mice fed HFD compared to their control on chow after 
60 minutes from insulin injection, whereas TRIB3-/- mice on chow and both groups on HFD 
had a significantly lower blood glucose concentration at 60 minutes post insulin injection 
compared to the start time point.  
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Figure 6. 5: Effect of TRIB3 on blood glucose in glucose-injected mice fed chow and 60% HFD (GTT) 
C57B6 and TRIB3-/- mice were fed chow or 60% HFD for 8 weeks and then starved overnight. Blood was 
collected from tail to take a baseline glucose reading before intraperitoneal injection of the mouse with sterile 
glucose at 10 ul/g BW (20% D-glucose). Readings were taken at different time points (0, 30, 60, 90 and 120 
minutes). Data show mean ± SEM in mmol/l. Each group is represented by 5 or 7 mice at each time point. 
Statistical significance was tested using one-way ANOVA, followed by Bonferroni Post Test (** p < 0.01 and                 
**** p < 0.0001). 
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Figure 6. 6: Effect of TRIB3 on blood glucose in insulin-injected mice fed chow and 60% HFD (ITT) 
C57B6 and TRIB3-/- mice were fed chow or 60% HFD for 11 weeks and then fasted for 2-3 h. Blood was 
collected from tail to take a baseline glucose reading before intraperitoneal injection of the mouse with sterile 
insulin at 0.75 U/kg BW (0.25 U/ml). Readings were taken at different time points (0, 20, 40 and 60 minutes). 
Data show mean ± SEM in mmol/l. Each group is represented by 5 or 7 mice at each time point. Statistical 
significance was tested using one-way ANOVA, followed by Bonferroni post test (** p < 0.01 and                  
**** p < 0.0001). C57B6 served as a control. 
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E) Role of TRIB3 in control lipid homeostasis in mouse blood fed 
chow and 60% HFD 
TRB3 has been linked to insulin resistance [153] and metabolic syndrome [206]. Part of these 
disease processes is dysregulated plasma lipid levels. Therefore, I investigated the 
consequences of TRIB3 deficiency on plasma lipid profile.	  The function of TRIB3 on lipid 
homeostasis was investigated in mouse blood after feeding mice normal and 60% HFD for 11 
weeks. The following graphs show knocking out TRIB3 decreased cholesterol and HDL 
concentrations in the blood significantly compared to the control in mice fed 60% HFD, but not 
in mice on normal diet. In contrast, the diet itself had an effect as feeding mice 11 weeks HFD 
increased cholesterol and HDL concentrations significantly of both groups (Figures 6.7A and 
6.7B).	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Figure 6. 7: Effect of TRIB3 on lipid homeostasis in mouse blood fed chow and 60% HFD 
Blood plasma was collected from C57B6 versus TRIB3-/- mice post chow and 60% HFD feeding for 11 weeks. 
A-C represent cholesterol, HDL and TG levels respectively for both groups, which were measured via enzymatic 
colorimetric test by the department of Clinical Chemistry, using Cobas 8000 system. Data shows mean ± SEM in 
mmol/l. Each group is represented by 5 or 7 mice at each condition. Statistical significance was tested using one-
way ANOVA, followed by Bonferroni post test(* p < 0.05, ** p < 0.01 and *** p < 0.001). 
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F) Role of TRIB3 in the development of atherosclerosis in mouse fed 
60% HFD 
It has been demonstrated that TRIB3 is involved in atherosclerosis disease [171]. The present 
study aims to investigate further whether TRIB3 is implicated in this disease. The function of 
TRIB3 in metabolic processes which contribute to atherosclerosis development was 
investigated in mice fed 60% HFD for 11 weeks. Aortas were stained by Oil Red O, while each 
heart sinus by H&E. As a result, graphs show that neither diet nor knocking out TRIB3 had an 
effect on developing lesions on aorta or heart sinus. This is illustrated in figures 6.8A-D. 
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Figure 6. 8: Effect of TRIB3 on developing plaque in mice fed 60% HFD 
Histological analysis of aortas and heart sinuses of C57B6 and TRIB3-/- mice on 60% HFD for 11 weeks. Seven 
aortas were obtained from each group stained with Oil Red O. Images A and B are representatives of each group. 
Two to three heart sections were obtained from each group stained with H&E, images C and D are representatives 
of each microscopic heart sinus of C57B6 and TRIB3-/-. Valve leaflet (A), lumen (B), aortic sinus (C) and 
surrounding heart muscle (D). 
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G) Role of TRIB3 in heart sinus cells architecture in mouse fed 60% 
HFD 
The current study also aims to investigate whether TRIB3 has an effect on heart sinus cells 
architecture. The function of TRIB3 in these cells was investigated in mice fed 60% HFD for 
11 weeks. Heart sinuses were stained by H&E. As shown in the graphs 6.9A and 6.9B TRIB3 
deficiency had no effect on heart sinus cells architecture, given no differences found between 
C57B6 and TRIB3-/- groups. 
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Figure 6. 9: Effect of TRIB3 on heart sinus cells architecture in mouse fed 60% HFD 
Histological analysis of heart sinus of C57B6 and TRIB3-/- mice on 60% HFD for 11 weeks. Two to three heart 
sinus sections were obtained from each group stained with H&E. Images A and B are representatives of each 
microscopic heart sinus cells architecture of C57B6 and TRIB3-/-. 
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H) Liver and adipose tissue histology of C57B6 and TRIB3-/- mice 
fed chow and 60% HFD 
Previous studies have shown that TRB3 is expressed in liver and adipose tissue [169]. This 
experiment aims to investigate whether TRB3 modulates the phenotype of these tissues. 
Histological analysis of tissues was investigated in C57B6 and TRIB3-/- mice on chow and 
60% HFD for 11 weeks. Sections were stained with H&E. Figures 6.10A-D show no difference 
in liver cells of all 4 group. Figures 6.11A-D illustrate no difference in adipose cells between 
C57B6 and TRIB3-/- mice on chow, while an increase in cell size of both groups fed HFD and 
even TRIB3-/- was larger when compared to C57B6 on the same diet.   
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Figure 6. 10: Liver histology of C57B6 and TRIB3-/- mice fed chow and 60% HFD 
Histological analysis of liver of C57B6 and TRIB3-/- mice on chow or 60% HFD for 11 weeks. Sections were 
obtained from 3 mice from each group chow and HFD fed stained with H&E. Images A and B are representatives 
of microscopic liver cells of C57B6 and TRIB3-/- mice on chow, while images C and D on HFD. 
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Figure 6. 11: Adipose tissue histology of C57B6 and TRIB3-/- mice fed chow and 60% HFD 
Histological analysis of adipose tissue of C57B6 and TRIB3-/- mice on chow or 60% HFD for 11 weeks. Sections 
were obtained from 3-5 mice from each group chow and HFD fed stained with H&E. Images A and B are 
representatives of microscopic adipose cells of C57B6 and TRIB3-/- mice on chow, while images C and D on 
HFD. 
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I) The effect of TRIB3 deficiency in determining macrophage 
numbers in heart, liver and adipose tissue 
Infiltration of macrophages in the development of atherosclerosis and metabolic syndrome has 
been demonstrated. These cells are believed to be important local drivers of tissue 
inflammation [9], [207]. The importance of TRIB3 in determining macrophage numbers in 
heart, liver and adipose tissue was studied in mice fed 60% HFD for 11 weeks. This was also 
shown in adipose tissue for chow fed mice. Heart sinus, liver and adipose tissue were incubated 
with F4/80 antibody (the marker of macrophages; primary antibody), biotinylated anti-rat IgG 
(secondary antibody), Vectastain ABC-HRP reagent and DAB before counterstaining by 
haematoxylin. Macrophages in these tissues were then counted. As a result, graphs 6.12A-D 
and 6.13A-F show neither heart nor liver had macrophages in C57B6 and TRIB3 mice fed 
HFD. With respect to adipose tissue of mice on chow graphs 6.14A-F illustrate no 
macrophages in either group. However, feeding mice HFD led to an insignificant increase 
macrophage number in adipose tissue, whereas TRIB3 deficiency had no effect on 
macrophages, as no differences were found between C57B6 and TRIB3-/- mice graphs   
6.14G-L. 
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Figure 6. 12: The importance of TRIB3 in determining macrophage number in heart of mouse fed 60% 
HFD 
Histological analysis of heart sinus of C57B6 and TRIB3-/- mice on 60% HFD for 11 weeks. Two to three heart 
sinus sections were obtained from each group incubated with F4/80 antibody (the marker of macrophages; primary 
antibody), biotinylated anti-rat IgG (secondary antibody), Vectastain ABC-HRP reagent and DAB before staining 
by haematoxylin. Images A and B are representatives of microscopic heart sinus of C57B6, while C and D are 
representatives of TRIB3-/-. Macrophage (M). 
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Figure 6. 13: The importance of TRIB3 in determining macrophage number in liver of mouse fed 60% 
HFD 
Histological analysis of liver of C57B6 and TRIB3-/- mice on 60% HFD for 11 weeks. Three liver sections were 
obtained from each group incubated with F4/80 antibody (the marker of macrophages; primary antibody), 
biotinylated anti-rat IgG (secondary antibody), Vectastain ABC-HRP reagent and DAB before staining by 
haematoxylin. Images A-C are representatives of microscopic liver of C57B6, while D-F are representatives of 
TRIB3-/-. Macrophage (M). 
A	   D	  
B	   E	  
C	   F	  
M 
M 
C57B6 
C57B6 
C57B6 
TRIB3-/-
6 
TRIB3-/- 
TRIB3-/- 
	   138	  
 
 
 
                  
 
 
 
Chow 
C	  
A	  
B	  
D	  
E	  
F	  
C57B6 
C57B6 	  
C57B6 	   TRIB3-/- 	  
TRIB3-/- 	  
TRIB3-/- 
	   139	  
                  
 
Figure 6. 14: The importance of TRIB3 in determining macrophage number in adipose tissue of mouse fed 
chow and 60% HFD 
Histological analysis of adipose tissue of C57B6 and TRIB3-/- mice on chow and 60% HFD for 11 weeks. Three 
adipose tissue sections were obtained from each group incubated with F4/80 antibody (the marker of 
macrophages; primary antibody), biotinylated anti-rat IgG (secondary antibody), Vectastain ABC-HRP reagent 
and DAB before staining by haematoxylin. Images A-C are representatives of microscopic adipose of C57B6, 
while D-F are representatives of TRIB3-/- both on chow.  Images G-I are representatives of microscopic adipose 
of C57B6, while J-L are representatives of TRIB3-/- both on HFD. Macrophage (M). 
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6.3 Discussion  
The literature has described the essential regulatory role for TRIB3 in lipid homeostasis and 
insulin resistance. A study by Ord et al in 2007 demonstrated that TRIB3 has a role in 
protecting cells against the growth inhibitory and ATF4 cytotoxic effect [208]. 
Further research has looked into the role of TRIB3 in insulin resistance and its effects on 
diabetes. Du et al demonstrated that TRIB3 may act as a down-regulator of Akt activation by 
insulin in murine liver, by linking and interfering with Akt activation. Therefore, TRIB3 
contributes to insulin resistance in individuals liable to type II diabetes [153]. 
This study investigated the impact of TRIB3 in various experiments in C57B6 and TRIB3-/- 
groups fed chow and 60% HFD for 11 weeks. When looking at its impact on weight gain, the 
graphs indicated that TRIB3-/- and HFD have a role in increasing murine weight gain 
significantly. Both groups were weighed weekly and matched with their ages (Figure 6.1A), 
and as the weight of TRIB3-/- mice at start point was greater than the control and remained 
elevated with increasing age, percentage weight gain was assessed and results plotted on a 
graph (Figure 6.1B). This is to ensure that the increase in mouse weight gain was due to 
knocking out TRIB3 in addition to feeding the mice HFD, not due to TRIB3-/- mice weighing 
more than the control at the start of the experiment. This project proved that the effect of 
TRIB3 knockout on weight was gender specific, as TRIB3-/- males on chow weighed 
significantly more than C57B6 mice, however, no difference was found in females (Figures 
6.2A and 6.2B). 
The role of TRIB3 in insulin resistance in murine blood fed chow and 60% HFD was 
investigated. Figure 6.5 showed that knocking out TRIB3 as well as HFD have an effect on 
blood glucose level as the level of glucose remained elevated significantly in TRIB3 -/- mice 
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on HFD, while it returned to the base line after 2 hours from injection in other groups (both 
C57B6 groups on chow and HFD, and TRIB3-/- group on chow). In addition to this, from     
30-120 minutes and from 60-120 minutes TRIB3-/- mice on HFD showed a significantly 
higher glucose level compared to the TRIB3-/- mice on chow and C57B6 on HFD respectively. 
Therefore, TRIB3 may be required to control murine blood glucose level through regulating 
glucose metabolism, and TRIB3 impairment may lead to develop insulin resistance. Figure 6.6 
confirmed the results of figure 6.5 by illustrating groups fed HFD (C57B6 and TRIB3-/- mice) 
as well as TRIB3-/- mice on chow, which showed a significant decrease in glucose level at    
60 minutes after insulin injection compared to 0 minute time point. However the glucose level 
of C57B6 on chow returned to the normal level at starting point. In other words, TRIB3 could 
have a key role in maintaining normal blood glucose level, and its deficiency decreases 
releasing glucose from tissues to the blood. 
A study by Koo et al in 2004 proposed that inhibition of TRIB3 may treat type II diabetes as in 
liver, PGC-1 promotes insulin resistance via PPAR-α-dependent induction of TRIB3 [155]. 
Furthermore, Okamoto et al (2007) documented that TRIB3 deficiency displays normal hepatic 
insulin signalling and glucose homeostasis in mice [169]. Also looking at insulin resistance, 
Weismann et al in 2011 proposed that in vivo TRIB3 inhibition improves insulin sensitivity via 
PPAR-γ activation and without any alteration in RAC-beta serine/threonine-protein kinase 
(Akt2) activity in a rat model of insulin resistance [170]. 
Unger et al in 2003 suggested that insulin resistance results secondary to lipid accumulation, 
which occurs due to full responsiveness to insulin-stimulated lipogenic activity [209]. 
Takahashi et al (2008) demonstrated TRIB3 down-regulates PPAR-γ, a master controller of 
adipocyte differentiation, and regulates adipogenesis [137]. Furthermore, Wang et al in 2012 
recorded that TRIB3 silence in diabetic ApoE-/-/LDL receptor-/- mice suppresses 
	   142	  
atherosclerosis and stabilises plaques [171]. Oberkofler et al in 2010 showed in insulin-
resistant obese human’s atypical hepatic TRIB3 gene expression [210]. The previous literature 
demonstrates the important regulatory function of TRIB3 in lipid homeostasis and insulin 
sensitivity.  
In addition to the effect of TRIB3 on insulin resistance, its role on lipid homeostasis was 
studied in murine blood fed chow and 60% HFD. Graphs 6.7A and 6.7B demonstrated that diet 
has an influence on modulating lipid homeostasis as feeding HFD to mice for 11 weeks 
significantly increased cholesterol and HDL concentrations in both groups. Further to this, 
TRIB3-/- altered the proportion of the increase as there was a rise in cholesterol and HDL 
levels post feeding HFD by 2 and 2.3 fold respectively in C57B6 group, whereas by 1.3 and 1.5 
fold respectively in TRIB3-/- group. TRIB3 deficiency itself did not show any significant 
effect on lipid homeostasis in mouse blood except if the mice were fed a HFD. Here, it 
decreased cholesterol and HDL concentrations significantly in murine blood on 60% HFD for 
11 weeks compared to their controls fed the same diet, but not in mice on a normal diet.  
The above results indicate that on a HFD TRIB3 may be involved in lipid release from tissues, 
such as adipose tissue, to the blood to maintain lipid homeostasis. TRIB3 deficiency may 
therefore lead to an increased tissue lipid storage, which results in decreased blood lipid. By 
contrast, figure 6.7C illustrated neither diet nor knocking out TRIB3 have an effect on TG 
concentration. Given the above TRIB3 may regulate lipid homeostasis in mouse blood when 
fed a 60% HFD, however, molecular mechanism of TRIB3 action remains unclear. 
Histological analysis of liver and adipose tissue were investigated in C57B6 and TRIB3-/- mice 
fed chow and 60% HFD for 11 weeks. The results showed no difference between liver cells of 
both groups whether mice were on chow or HFD (Figures 6.10A-D). Also no difference was 
found in adipose cells of both groups on chow. However, feeding mice HFD increased adipose 
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cell size of C57B6 and TRIB3-/-. In addition to this, knocking out TRIB3 resulted in a further 
increase in cell size when compared to C57B6 on the same diet (Figures 6.11A-D). In other 
words, TRIB3 may have a role on lipid release from adipose cells to the blood and knocking it 
out may increase lipid storage in these cells, which in turn increase cell size. This supports the 
above findings. It could also be that TRIB3 deficiency leads to a decrease in cell mitosis, 
therefore, reducing cell numbers and increasing cell size compared to its control on the same 
diet, or it may be due to a combination of both. 
Furthermore, the role of TRIB3 on WBC numbers in the peritoneal lavage fluid in mice fed 
60% HFD was studied. It was evident that knockout TRIB3 significantly increased leukocyte 
numbers in peritoneum compared to C57B6 (Figure 6.3A). However, neutrophils were not 
observed in both groups (Figures 6.3B and C). This suggests that TRIB3 is not necessary to 
control the number of all WBC types in peritoneum as it has no effect on neutrophil number. 
The role of TRIB3 on WBC circulating in mouse blood fed chow and 60% HFD can be seen in 
graph 6.4A which illustrates no significant difference in the number of leukocytes in TRIB3-/- 
blood compared to the control regardless of whether mice were on normal food or HFD. 
However, post prolonged time (11 weeks) feeding both groups 60% HFD resulted in a 
significantly lower leukocyte numbers than feeding them for 5 weeks. With regards to the 
numbers of leukocyte types that are in murine blood, lymphocytes were shown to predominate 
in both groups whether mice are chow or HFD fed, with the exception of C57B6 group that 
were fed chow as the majority were lymphocytes and neutrophils (graphs 6.4B–D). 
Interestingly, figures 6.4B–D also display among leukocyte types, knocking out TRIB3 
decreased only neutrophil number significantly in mice fed normal food. It is possible that the 
decrease in neutrophils is compensated by other type of leukocytes as in figure 6.4A there were 
no difference in leukocyte numbers between C57B6 and TRIB3-/- mice fed chow. However, 
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the impact of feeding the mice 60% HFD is seen clearly on decreasing neutrophil and 
monocyte numbers in both blood groups (Figures 6.4C–D), while the significant decrease in 
lymphocyte number was restricted to C57B6 group on diet for 11 weeks compared to 5 weeks 
feeding of the same group (Figure 6.4B). Furthermore, the percentage of cells in blood was 
measured, figures 6.4E–G displayed knocking out TRIB3 increased the percentage of 
lymphocytes significantly, whereas the percentage of neutrophils was apparently decreased, but 
no effect was seen on the percentage of monocytes in mice fed chow. In contrast, feeding 
TRIB3-/- mice 60% HFD for short term (5 weeks) resulted in a significant decrease in the 
percentage of lymphocytes compared to C57B6 group on the same diet. In addition to this, 
measuring the percentage demonstrates the significant impact of diet, as monocytes in addition 
to neutrophils were decreased, whereas lymphocytes increased considerably in both C57B6 and 
TRIB3-/- groups. 
This study also investigated the function of TRIB3 in developing lesions on aorta and heart 
sinus in mice fed 60% HFD for 11 weeks and clearly found both TRIB3 and feeding the mice 
HFD have no influence on atherosclerosis development in both areas (Figures 6.8A–D). 
Furthermore, TRIB3 has no effect on the heart sinus architecture as illustrated in figures 6.9A 
and 6.9B. 
When looking at the heart, Ti et al (2011) showed in a type 2 diabetic rat model TRIB3 gene 
silencing alleviates diabetic cardiomyopathy [138]. Gong et al in 2009 found people with 
TRIB3 functional Q84R polymorphism are at risk of metabolic syndrome and carotid 
atherosclerosis [206]. 
Data shows there were almost no macrophages present in the heart sinus and liver in C57B6 or 
TRIB3-/- mice on HFD, in addition to adipose tissue of both groups fed chow. This indicates 
that TRIB3 has no role in determining macrophage numbers in these tissues (Figures 6.12A–D 
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and 6.13A–F). On the other hand, this diet may have an effect on adipose tissue, as adipose in 
both groups fed HFD have reduced macrophage numbers compared to their controls on chow. 
Again, knockout TRIB3 did not have a role in determining macrophage number in adipose, as 
the macrophage numbers in adipose of C57B6 and    TRIB3-/- mice on HFD was similar 
(Figures 6.14A–L).  
All of the above data suggest TRIB3 deficiency and HFD in combination modulate murine 
weight gain significantly. It also supports the theory that TRIB3 and HFD have an impact on 
WBC numbers in peritoneum and blood. However, their effect varies and depends on several 
factors as follows: leukocyte type, the mice diet and period of HFD. In addition, gender 
appears to play a key role on the weight of TRIB3-/- mice, which were fed chow compared to 
C57B6. 
TRIB3 may be required to control murine blood glucose levels through regulation of glucose 
metabolism and glucose release from the tissues. TRIB3 deficiency may have a role in insulin 
resistance. Nevertheless, TRIB3 may be involved in controlling lipid homeostasis in mouse 
blood fed 60% HFD; neither diet nor knocking out TRIB3 has an effect on atherosclerosis 
development in mice. TRIB3 could also play a part in cell mitosis, specifically adipose but 
showed no effect on heart sinus architecture and macrophage number in all of murine heart 
sinus, liver and adipose in mice fed 60% HFD as seen in this study.  
Further investigations on TRIB3 need to be conducted in addition to critical questions to be 
addressed, assessing its function. These include the molecular mechanism of TRIB3 action on 
lipid homeostasis, its impact on WBC numbers as well as identification of its exact role on 
insulin sensitivity. 
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Chapter 7: General Discussion 
	  
The discussion that follows below is an analysis of the experiments conducted in view of the 
hypothetical propositions put forward and the aims outlined in the thesis. 
It has been published by Nick et al in 2000 that there is greater dependence on p38 MAPK 
pathway in the neutrophil compared to other WBC [182]. A study by Knall et al demonstrated 
that neutrophil chemotaxis towards IL8 is PI3K-dependent [183], [184]. Our observations 
strongly suggest that TRIB3 does not control activation of neutrophils via p38 MAPK. Its 
deficiency does not alter p38 phosphorylation compared to C57B6, or it may be that its effect is 
minute to the extent it is undetectable by western blotting technique. Data clearly highlights no 
profound differences between TRIB3-/- mice and the control in neutrophil chemotaxis to KC or 
fMLP. However, there was a trend to an increased response to KC at 10-5 M in TRIB3-/- mice 
compared to C57B6. There was also a trend to an increased response to fMLP at 10-6 M and  
10-7 M. This suggests that knockout TRIB3 increased sensitivity of neutrophil chemotaxis 
towards chemoattractant. Hence, TRIB3 may regulate neutrophil migration in response to 
different chemoattractants (KC and fMLP). To see a significant effect, the number of 
experiments conducted should be increased. This study also clearly indicates that different 
signaling cascades for various stimuli regulate neutrophil chemotaxis. For more conclusive 
results, it would be beneficial if further in vitro studies on the effect of TRIB3 on neutrophil 
function via different intracellular signalling cascades in response to varying chemoattractants 
are conducted.  
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Siddiqi et al in 2001 demonstrated CD11b expression is clearly increased in PMA-stimulated 
neutrophils [194]. This study would suggest that once TRIB3 is knocked out and the cells are 
stimulated, the effect of shedding of L-selectin from the cell surface is significant. It is clear the 
key in increasing CD11b expression is the stimulation of cells rather than TRIB3-/- effect, 
while with PSGL-1, neither removing TRIB3 nor stimulating the cells has an effect on PSGL-1 
expression. These observations clearly exclude the considerable effect of TRIB3 on adhesion 
molecules expression on murine neutrophils. The varying results in the literature and also with 
the in vitro observations of this project may have been due to various reasons, such as possible 
infection of mice and technical differences.  Literature studies have shown discrepancies in this 
area and observations in this study support these findings. Given the variations in research and 
the findings of this experiment, further in vitro studies on the effect of TRIB3 on adhesion 
molecules would be recommended. 
 
Interestingly, the effect of TRIB3 deficiency was observed in the blood of mice with 
thioglycollate-induced peritonitis. Knocking out TRIB3 inhibits the increase in leukocyte 
number in the samples significantly, while there was no effect on leukocyte chemotaxis 
towards the peritoneum compared to the control. Also knockout TRIB3 in mice with 
thioglycollate-induced peritonitis may increase sensitivity of neutrophil migration. There was a 
trend of increase neutrophil chemotaxis to peritoneum at 2 hours in TRIB3-/- mice compared to 
C57B6. This result was confirmed by the data found when studying the effect of TRIB3 on 
murine neutrophil chemotaxis in response to KC and fMLP. Neutrophil influx of TRIB3-/- 
mice towards KC at 10-5 M and fMLP at 10-7 M and 10-6 M was greater than C57B6, but this 
was not significant. It is also clear that removing TRIB3 from mice with thioglycollate-induced 
peritonitis had no significant effect on neutrophil chemotaxis. Furthermore, neutrophil 
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chemotaxis in TRIB3-/- mice persisted and continued to increase at 24 hours compared to the 
control which reduced after 6 hours until a minute number migrated at 24 hours (again there 
was no significance); a potential explanation for this could be that TRIB3 deficiency delays 
neutrophil apoptosis. 
It was found that the initial process occurring after introducing thioglycollate, is the increasing 
levels of neutrophil-attracting chemokines at the site of infection. Research has showed that  
IL-13 activates human neutrophils to modulate the synthesis of many neutrophil proteins [203]. 
There was an increase in cytokine concentrations with time for both thioglycollate-induced 
peritonitis groups. When TRIB3 was removed from murine cells, the effect on cytokines was 
more selective and time dependent i.e. GMCSF, IL-17A and MCP-1 were affected at 2 hours 
and IL-13 at 6 hours compared to the control. However, the findings were not statistically 
significant except for IL-13. It could be that TRIB3 down regulates these cytokines at a certain 
point in time, although this regulation has no significant effect on neutrophil chemotaxis. The 
mechanism by which neutrophils recruit between endothelia and migrate into the inflammatory 
site warrants further investigation. Clarification of the link between TRIB3 and cytokines in 
vivo is hindered by the fact that the mechanism remains unclear, although cytokines are a 
prerequisite for neutrophil chemotaxis and TRIB3 appears to regulate these. 
Literature has looked into the role of TRIB3 in lipid homeostasis and insulin resistance.         
Du et al observed that TRIB3 may act as a down-regulator of Akt activation by insulin in 
murine liver. Hence, TRIB3 contributes to insulin resistance in individuals susceptible to type 
II diabetes [153]. The results of this study reveal that TRIB3 is possibly required for control of 
murine blood glucose level through regulation of glucose metabolism. It also shows that 
TRIB3 impairment may lead to insulin resistance. Essentially, TRIB3 could have a key role in 
maintaining normal levels of blood glucose. Its deficiency reduces the release of glucose from 
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tissues to the blood. However, a study by Koo et al in 2004 proposed that inhibition of TRIB3 
may help in the treatment of type II diabetes [155]. A further study by Wang et al in 2012 
supporting Koo, documented that silencing TRIB3 in diabetic ApoE-/-/LDL receptor-/- mice 
suppresses atherosclerosis and stabilises plaques [171]. Additionally, TRIB3 deficiency and 
HFD in combination increase murine weight gain. Gender also play a key role on the weight of 
TRIB3-/- mice fed chow compared C57B6. Furthermore, this study demonstrates that HFD has 
an effect on modulating lipid homeostasis. It significantly elevated cholesterol and HDL levels 
in both groups. Likewise, TRIB3 deficiency altered the proportion of the increase as the rise in 
cholesterol and HDL levels were approximately double in C57B6 compared to the TRIB3-/- 
group. Knocking out TRIB3 also reduced cholesterol and HDL levels significantly in murine 
blood on HFD. This may indicate that on a HFD TRIB3 may be involved in lipid release from 
tissues to the blood in maintaining lipid homeostasis. In other words, the knocking out may 
therefore elevate tissue lipid storage, which reduced blood lipid. Again the molecular 
mechanism of TRIB3 action to regulate lipid homeostasis in mouse blood when fed a HFD 
remains uncertain. 
Feeding mice HFD led to an increase in adipose cell size in both groups; however, TRIB3 
deficiency resulted in a further increase in cell size. This again suggests that TRIB3 may have a 
role on lipid release from adipose cells to the blood. It may be possible that removing TRIB3 
leads to reduce cell mitosis, hence, decreasing cell numbers and increasing cell size compared 
to its control on the same diet, or it could be due to a combination of both. 
Moreover, it was evident that TRIB3 deficiency significantly elevated leukocyte numbers in 
peritoneum of mice on 60% HFD. However, TRIB3 is not necessary to regulate numbers of all 
WBC types in peritoneum as it has no effect on neutrophil number. Noticeable results in this 
study suggest that HFD decreased blood leukocyte numbers in both groups. Interestingly, 
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amongst leukocyte types, removing TRIB3 only reduced neutrophil number significantly in 
mice fed normal food. However, the effect of feeding the mice HFD is seen clearly on reducing 
neutrophil and monocyte numbers in both blood groups, whereas the significant decrease in 
lymphocytes was restricted to C57B6 group. 
This study also demonstrates clearly that both TRIB3 and feeding the mice HFD have no effect 
on developing lesions in aorta and heart sinus, although Gong et al in 2009 found people with 
TRIB3 functional Q84R polymorphism are at risk of metabolic syndrome and carotid 
atherosclerosis [206]. TRIB3 equally has no effect on the heart sinus architecture as seen in this 
research. In addition, there were almost no macrophages present in the heart sinus and liver of 
either the C57B6 or TRIB3-/- mice on HFD. In contrast, both groups showed few macrophage 
numbers in adipose tissue compared to their controls on chow, suggesting HFD may increase 
macrophage number in this tissue. However, TRIB3 deficiency did not have an effect on 
macrophage number in adipose. 
This thesis concludes that neutrophil chemotaxis towards KC and fMLP, is dependent upon 
p38 MAPK and PI3K. These could be controlled by TRIB3, which regulates cytokine 
concentrations. Removing TRIB3 prevents the increase in circulating leukocyte count 
considerably, may increase neutrophil chemotaxis towards peritoneum (inflammation site) and 
may extend their existence in thioglycollate-induced peritonitis. This is possibly due to TRIB3 
deficiency interfering with neutrophil apoptosis. Moreover, TRIB3 and HFD affect murine 
weight gain. Gender also has a major effect on the weight of TRIB3 deficient mice fed chow 
compared to C57B6.  
TRIB3 and HFD have an effect on WBC numbers in peritoneum and blood. However, their 
effect is varied and depends on a range of factors. Furthermore, TRIB3 may regulate mitosis, 
blood glucose levels and lipid homeostasis. This study shows a link between TRIB3 deficiency 
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and susceptibility to insulin resistance. However there is no effect on atherosclerosis 
development and heart sinus architecture in mice nor macrophage number in murine heart 
sinus, liver and adipose tissue of mice fed 60% HFD. 
Contribution of TRIB3 in regulating lipid homeostasis is a novel finding. The role of TRIB3 in 
maintaining normal blood glucose level has been established previously and this has been 
further confirmed in this study. There is a relationship between this protein and neutrophilic 
inflammation. All the above provide new evidence for the close and complex link between 
TRIB3, insulin resistance, hyperlipidemia and inflammation. Therefore, this thesis raises the 
possibility of TRIB3 in the treatment of insulin resistance, inflammatory and metabolic 
diseases. Thus, focusing on TRIB3 may provide alternative strategies in the prevention and 
treatment of cardiovascular diseases. More studies on TRIB3 need to be conducted to further 
explore its various functions, for instance molecular mechanisms of its action on signalling 
pathways, WBC chemotaxis, lipid homeostasis and insulin sensitivity. 
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Appendix 1: Chemicals and other Laboratory substances 
  Item                                                                                 Supplier, Town, Country 
100bp DNA ladder Norgen, Thorold, Canada 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid, HEPES Sigma-Aldrich, Dorset, UK 
96-Well EASIA plates Sarstedt, Leicester, UK 
Accu-Chek Aviva test strips Roche, Burgess Hill, UK 
Acetic acid VWR, Lutterworth, UK 
Acrylamide stock solution (30%) Geneflow, Fradley, UK 
Agarose Bioline, London, UK 
Akt Ab New England Biolabs, Hitchin, UK 
Albumin solution (7.5%) Sigma-Aldrich, Dorset, UK 
Amersham HyperfilmTM ECL  Fisher, Loughborough, UK 
Ammonium persulphate, APS Sigma-Aldrich, Dorset, UK 
Anti-mouse CD115 AbD Serotec, Kidlington, UK 
Anti-mouse CD2 BD, Oxford, UK 
Anti-mouse CD45R eBioscience, Hatfield, UK 
Anti-mouse CD5 BD, Oxford, UK 
Anti-mouse F4/80 eBioscience, Hatfield, UK 
BD cytometric bead array, CBA, kit BD Biosciences, Oxford, UK 
Bio-Rad DC protein assay kit Bio-Rad, Hemel Hempstead, UK 
Biomix Bioline, London, UK 
Biotinylated anti-rat IgG Vector Laboratories, CA, USA 
Bovine serum albumin, BSA Sigma-Aldrich, Dorset, UK 
CellFIX BD, Erembodegem, Belgium 
Chemotaxis plates Receptor Technologies, Leamington Spa 
Cotton swabs Fisher Scientific, Loughborough, UK 
ddH20 (MilliQ H2O) Merck-Millipore, Watford, UK 
Dextran Sigma-Aldrich, Dorset, UK 
Di-sodium hydrogen orthophosphate, Na2HPO4 Sigma-Aldrich, Dorset, UK 
Diff-Quick BDH Merck Ltd, Poole, UK 
Dimethyl sulphoxide, DMSO Sigma-Aldrich, Dorset, UK 
Disposable haemocytometers Labtech International, Ringmer, UK 
DPX mounting medium Sigma-Aldrich, Dorset, UK 
Eosin solution Sigma-Aldrich, Dorset, UK 
Erythrolyse red blood cell lysing buffer AbD Serotec, Kidlington, UK 
Ethanol Fisher Scientific, Loughborough, UK 
Ethidium bromide, EtBr Sigma-Aldrich, Dorset, UK 
Ethylenediaminetetra-acetic acid, EDTA Sigma-Aldrich, Dorset, UK 
FITC rat anti-mouse Ly-6G (1A8)  BD, Oxford, UK 
Formaldehyde Sigma-Aldrich, Dorset, UK 
Formyl-methionyl-leucyl-phenylalanine, fMLP Sigma-Aldrich, Dorset, UK 
Glucose VWR, Lutterworth, UK 
Glycerol VWR, Lutterworth, UK 
Glycine VWR, Lutterworth, UK 
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Goat anti-rabbit-HRP Dako, Ely, UK 
Goat anti-rat mircobeads Miltenyi Biotech, Bisley, UK 
Haematoxylin solution Sigma-Aldrich, Dorset, UK 
Heparin sodium 5,000 IU/ml Leo Laboratories Ltd., Bucks, UK 
Hydrochloric acid VWR, Lutterworth, UK 
Hydrogen peroxide (H2O2) Sigma-Aldrich, Dorset, UK 
Ilford universal developer Jessop's, Leicester, UK 
Ilford, hypam fixer Jessop's, Leicester, UK 
Isofluorane Burtons, Marden, UK 
Isopropanol (propan-2-ol) Sigma-Aldrich, Dorset, UK 
Lipopolysaccharide, LPS Sigma-Aldrich, Dorset, UK 
MACS speration columns Miltenyi Biotech, Bisley, UK 
Methanol Fisher, Loughborough, UK 
Milk powder  
Murine KC Peprotech EC Ltd, London, UK 
N,N,N',N'-tetramethylethylenediamine, TEMED Sigma-Aldrich, Dorset, UK 
Nitrocellulose protran membrane Geneflow, Fradley, UK 
Oil Red O Sigma-Aldrich, Dorset, UK 
p38 inhibitor (SB 203580) Cell Signaling Technology, Danvers, MA, USA 
p38 MAP kinase assay kit  (nonradioactive)  New England Biolabs, Hitchin, UK 
p38 MAPK Ab New England Biolabs, Hitchin, UK 
Paraformaldehyde Sigma-Aldrich, Dorset, UK 
PE anti-mouse CD162 (PSGL-1) (2PH1) BD, Oxford, UK 
PE rat anti-mouse CD11b (M1/70) BD, Oxford, UK 
PE rat anti-mouse CD62L (L-selectin) (MEL-14) BD, Oxford, UK 
PE rat IgG1, κ isotype control BD, Oxford, UK 
PE rat IgG2a, κ isotype control BD, Oxford, UK 
PE rat IgG2b,  κ isotype control BD, Oxford, UK 
Pentobarbital sodium (20%) solution  Pharmacol Ltd., Andover, UK 
Peroxidase substrate kit (DAB) Vector Laboratories, CA, USA 
Phenylmethanesulphonylfluoride, PMSF Sigma-Aldrich, Dorset, UK 
Phorbol 12-myristate 13-acetate, PMA Sigma-Aldrich, Dorset, UK 
Phosphate buffered saline, PBS Oxoid, Basingstoke, UK 
Phospho Akt (ser473) New England Biolabs, Hitchin, UK 
Phospho p38 MAPK New England Biolabs, Hitchin, UK 
PI3K inhibitor (LY 294002) Cell Signaling Technology, Danvers, MA, USA 
Pierce supersignal west dura kit Fisher, Loughborough, UK 
Ponceau S solution Sigma-Aldrich, Dorset, UK 
Primers (LTR-2, LEXKO-1947-3’ and LEXKO-1947-5’) Sigma-Aldrich, Dorset, UK 
Protease inhibitor cocktail tablets Roche, Burgess Hill, UK 
Proteinase K Sigma-Aldrich, Dorset, UK 
Rainbow molecular weight  markers Fisher, Loughborough, UK 
Reblot plus mild stripping solution Millipore, Watford, UK 
Reducing agent (5x) Invitrogen, Paisley, UK 
RM AFE 60%FAT 20%CP 20%CHO (M) 25kGy Special Diets Services (SDS), Witham, UK  
RPMI media Lonza, Wokingham, UK 
Sodium chloride VWR, Lutterworth, UK 
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Sodium chloride (0.9%) Baxter, Thetford, UK 
Sodium dodecyl sulphate, SDS VWR, Lutterworth, UK 
Sodium fluoride, NaF VWR, Lutterworth, UK 
Sodium orthovanadate, Na3VO4 Sigma-Aldrich, Dorset, UK 
Sodium phosphate, NaH2PO4 Sigma-Aldrich, Dorset, UK 
Sodium pyrophosphate Sigma-Aldrich, Dorset, UK 
Thioglycollate Sigma-Aldrich, Dorset, UK 
Tri-sodium citrate Abcam, Cambridge, UK 
Tris (hydroxymethyl) methylamine, Tris VWR, Lutterworth, UK 
Tris-HCl Sigma-Aldrich, Dorset, UK 
Triton Sigma-Aldrich, Dorset, UK 
TRIzol reagent Life Technologies, Paisely, UK 
Tween-20 Sigma-Aldrich, Dorset, UK 
Vectastain ABC-HRP reagent Vector Laboratories, CA, USA 
Whatman filter paper, grade 3 Fisher, Loughborough, UK 
Xylene Sigma-Aldrich, Dorset, UK 
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Appendix 2: Equipment 
Avantic Centrifuge J-26 XP (Beckman, Germany) 
BD Vacutainer (K2EDTA)(BD, USA) 
C-Chip Disposable Hemocytometer (Digital Bio, Korea) 
Chemi Genius2 Bio Imaging System (Syngene, UK) 
Cytospin 2 (SHANDON, UK) 
FACSCalibur (BD Bioscience, USA) 
Fine insect pins (Fine Science Tools, Germany) 
G-STORM (Gene Technologies, UK) 
Laborlus Microscope (Leitz, Germany) 
LEICA RM2135 Microtome (Leica, Germany) 
Microfuge R Centrifuge (Beckman, Germany) 
NanoDrop N1000 (Thermo Fisher Scientific, USA) 
Nikon ECLIPSE E600 (Nikon Instruments Europe B.V., Amstelveen, The Netherlands) 
Nikon SMZ1000 (Nikon Instruments Europe B.V., Amstelveen, The Netherlands) 
Novex NuPAGE 4-12% Bis-Tris Gel (Life Technologies, USA) 
NuPAGE Minutei-Cell Electrophoresis (Life Technologies, USA) 
Plate Reader (Opsys MR, Dynex Technologies, USA) 
Refrigerated Centrifuge PK 120 R (ALC, Italy) 
Sysmex KX-21N Haematology analyser (Sysmex Corporation, Japan) 
UW Sonicator (Ultrawave Ltd, UK) 
Xcell IITM Blot Module (Life Technologies, USA) 
Xcell SureLockTM Minutei-Cell (Life Technologies, USA) 
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Appendix 3: Software 
CellQuest Pro version 3.01 (BD, USA) 
GeneSnap version 7.04 (SynGene, UK) 
GeneTools version 3.02 (SynGene, UK) 
GraphPad PRISM software version 5.00 (GraphPad Software Inc, USA) 
ND-1000 (Thermo Fisher Scientific, USA) 
Nis-Elements (Nikon Instruments Europe B.V., Amstelveen, The Netherlands) 
Revelation version 4.25 (Thermo Fisher Scientific, USA) 
	  
